Methods for controlling and / or restoring oxygen demand using mandibular repositioning devices
Customized mandibular repositioning devices with AI-integrated IoT technology enhance oxygen delivery and reduce airflow resistance in athletes and OSA patients by enlarging the airway, addressing EIAH and improving performance.
Patent Information
- Application Number
- PCT/US2026/027445
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-09
- Filing Date
- 2026-05-08
- Publication Date
- 2026-11-12
AI Technical Summary
Athletes and individuals with obstructive sleep apnea suffer from exercise-induced arterial hypoxemia (EIAH), which limits their peak performance due to reduced oxygen delivery and increased airflow resistance in the collapsible segment of the upper airway, and existing solutions are cumbersome or unsafe.
Customized mandibular repositioning devices with AI-integrated IoT technology are designed to increase the smallest concentric airway cross-sectional area (SMCA) using predictive algorithms, 3D printing, and adjustable flange geometries to enhance oxygen delivery and maintain oxygen saturation during physical exertion.
The devices effectively increase oxygen delivery and reduce airflow resistance, improving cardio-pulmonary efficiency, lactate threshold, critical power, and endurance by enlarging the retrolingual and retropalatal airway without the need for supplemental oxygen therapy.
Smart Images

Figure US2026027445_12112026_PF_FP_ABST
Abstract
Description
Attorney Docket 12572.012WO1METHODS FOR CONTROLLING AND / OR RESTORING OXYGEN DEMAND USING MANDIBULAR REPOSITIONING DEVICES TECHNICAL FIELD
[0001] This application relates to methods to track and guide improvements in health and fitness biometrics for users wearing or not wearing a mandibular repositioning device configured to increase that user’s smallest concentric airway cross-sectional area size during physical activity; more particularly, to custom-fabricated oral appliance systems that reposition the mandible and tongue base to effect antero-superior displacement of the hyoid bone, thereby enlarging the retrolingual and retropalatal airway, reducing pharyngeal collapsibility, and mitigating exercise-induced arterial hypoxemia (EIAH) in athletes and obstructive sleep apnea (OSA) in clinical populations.BACKGROUND
[0002] Many individuals suffer from exercise-induced arterial hypoxia (EIAH). EIAH is often discussed in terms of maximal oxygen consumption by the whole body, termed volume of oxygen maximum (VOanax). According to Dempsey and Wagner (1999), mild EIAH is characterized by an arterial oxygen saturation (Sa02) of 93-95% (or 3-4% below resting values), moderate EIAH as 88-93%, and severe EIAH as less than 88%. These parameters are based on the demonstrated effects of EIAH on maximal oxygen uptake (VCEmax), wherein even mild desaturation of 3-4% has been shown to reduce VCEmax by approximately 1-2%, while moderate-to-severe desaturation can produce substantially greater performance decrements. EIAH affects an estimated 50% of male endurance athletes with VCEmax values exceeding 55 mL / kg / min, and is similarly prevalent among highly trained female endurance athletes, representing a widespread but mechanically unaddressed limitation to peak human performance. Multiple physical determinants are used in discussing this phenomenon, such as running economy (i.e., an athlete’s performance efficiencies utilizing lower levels of VC>2max), lactate threshold (i.e., the closer the lactate threshold is to the VOanax, the higher the athlete’s performance), and critical power (i.e., the greatest metabolic rate where energy utilization is wholly oxidative) and how long the critical power can be sustained. Some other variables that have a correlation to EIAH include, but are not limited to, pulmonary ventilation, pulmonary capillary membrane diffusion, cardiac output, and physiological limitations like hemoglobin mass, peripheral circulation, and micro-diffusion.
[0003] Greater than 4-5% of partial pressure of oxygen (PaCb) reduction seen in some highly trained athletes limits their peak aerobic power. Further reduction in PaCU reduces VCUmax linearly at 1:2 ratio. Increasing effort of breathing incrementally decreases the size of the collapsible segment or smallest concentric airway cross-sectional area (SMCA) of the upperAttorney Docket 12572.012WO1airway. The SMCA on average is about 149 mm2. Decreasing the SMCA incrementally increases airflow resistance and work of breathing, reduces O2 delivery. Conversely, increasing the SMCA results in increased alveolar O2 delivery (arterial O2 supply (DChmax) over demand (VC>2max). Harms et al. teach that increased O2 content and O2 delivery eliminated EIAH and increased V02max by 200%.
[0004] EIAH or exercise-induced arterial hypoxemia is observed at peak power output in some elite athletes. These athletes are limited in their performance when such an event occurs. Usually there is a >4%-5% drop in oxygen levels from their normal levels at this time and in some athletes as low as 74%. For at least a hundred years it has been unknown as to why some elite athletes experience this while others who are just as elite do not. There have been many reported deaths during peak performance in athletes in every form of sport. Studies have shown that if supplemental oxygen was given, these athletes do not experience a drop in oxygen. But it is very difficult (and, in some sport, is unsafe) to strap an oxygen cylinder on an athlete’s back.
[0005] The pathophysiology of EIAH is multifactorial. Both an excessive alveolar-to-arterial PO2 difference (A-aDCh exceeding 25-30 Torr) and inadequate compensatory hyperventilation (arterial PCO2 remaining above 35 Torr during heavy exercise) commonly contribute to the arterial desaturation observed during maximal and near-maximal exertion. Additionally, acid-and temperature-induced rightward shifts in the oxyhemoglobin dissociation curve reduce SaCE at any given arterial PO2. Expiratory flow limitation presents a significant mechanical constraint to exercise hyperpnea, while ventilation-perfusion ratio maldistribution and diffusion limitation contribute approximately equally to the excessive A-aDCE. The exact mechanisms by which diffusion limitation is incurred or how ventilation-perfusion ratio becomes maldistributed with heavy exercise remain incompletely understood and continue to be subjects of active physiologic investigation.
[0006] In the Applicant’s prior pending applications, it was shown that (i) increasing effort of breathing incrementally decreases size of collapsible segment of the upper airway, (ii) a decreasing SMCA incrementally increases airflow resistance and work of breathing; thus, reducing 02 delivery, (iii) an increase in the SMCA increased alveolar O2 delivery (aDO2), increased arterial O2 supply (D02max and SaO2) and increased the delta between O2 supply and O2 demand / consumption (VO2 max), (iv) an increase in D02max and delta 02max (D02max) resulted in improved cardio-pulmonary efficiency, higher lactate threshold (LR), greater critical power (CPR and CPA), improved endurance, speed and peak power at lower heart rate, (v) an increase in the SMCA during peak performance improved performance (strength, speed endurance) without supplemental O2 therapy during competitive sports.Attorney Docket 12572.012WO1
[0007] There is a need to provide individuals, such as athletes, suffering from EIAH with a solution, especially one that is simple to implement, such as the customized mandibular repositioning devices disclosed herein and in applicant’s co-pending applications filed on the same day as this application, each of which is incorporated herein by reference in its entirety.SUMMARY
[0008] Disclosed herein is a method and oral appliance having a user customized design to deliver an individual, such as an athlete, more oxygen (raise max O2 delivery) with any one of the oral appliances disclosed in U.S. patents 11,666,477, 11,666,478, 11,806,273, and 11,819,449, U.S. applications 17 / 098,355, 17 / 366,421, 18 / 466,365, 18 / 890,703 and US provisional application 63 / 802,715 modified to have a matched AI-integrated-IoT custom geometry with demonstrable improvement in oxygen delivery, even beyond a user’s natural oxygen levels. Each of these patents and pending applications are incorporated herein by reference in their entirety.
[0009] In all aspects, methods for restoring oxygen delivery in a user experiencing exercise-induced arterial hypoxemia are described herein. The methods include determining at least one EIAH-related biologic data of the user; inputting the at least one EIAH-related biologic data and preselected biological data of the user into a predictive algorithm stored in nontransitory memory of a microprocessor; generating, via the predictive algorithm, a flange geometry for a mandibular repositioning device configured to increase the user’s partial pressure of oxygen (PaCh) to at least a rest-state value during exercise; and fabricating the mandibular repositioning device according to the flange geometry generated by the predictive algorithm. Fabricating the mandibular repositioning device can include3-D printing and / or additive manufacturing thereof.
[0010] The mandibular reposition device can have lateral mating flanges or occlusal mating flanges. When the flanges are lateral mating flanges, the maxillary piece having a driver flange protruding laterally outward on either or both of the right side and left side thereof, each driver flange having an anterior side with a convex curvature; and the mandibular piece having a protrusive flange extending cranially therefrom positioned to have a posterior side engaged with the anterior side of the driver flange, the posterior side of each protrusive flange has a concave-to-convex curvature from a base of the protrusive flange toward a most cranial point of the protrusive flange and a convex portion of the concave-to convex curvature engages the convex curvature of the driver flange in a rest position. The mandibular piece also has a plateau of a preselected height between a base of the protrusive flange and the mandibular piece.
[0011] When the flanges are occlusal mating flanges, a mandibular piece comprising a platform along a superior occlusal surface that defines a first ramped surface with a rise oriented anteriorly and a first flange extending cranially upward from an anterior end of the platform,Attorney Docket 12572.012WO1wherein the posterior side of the first flange is oriented at a posterior lean in a range of 3 to 20 degrees relative to the superior occlusal surface and contoured as a (i) concave curvature or (ii) a concave-to-convex surface in the caudal to cranial direction; a maxillary piece comprising a second flange that extends caudally downward from an inferior occlusal surface thereof, wherein, in a rest position, the second flange has a caudal side shaped to seatingly mate to the platform of the mandibular piece and an anterior side with an opposite surface contour shaped to seatingly mate to the posterior side of the first flange, thereby defining a wedge-shaped column having its rise defined by the height of the first flange separating the mandibular piece from the maxillary piece and defining a static open mouth position, wherein the static open mouth position is configured to maintain a user’s oxygen concentration in the bloodstream at a pre-selected concentration, and downward movement of the mandibular piece moves the posterior side of the first flange along and in contact with the anterior surface of the second flange for gradual incremental forward mandibular movement, which increases the cross-sectional area of the user’s airway.
[0012] The method further comprises validating the user’s secondary biometrics while wearing the mandibular repositioning device with the flange geometry. Validating can include measuring the biometrics during peak performance conditions and / or inputting the secondary biometrics into the predictive algorithm and assessing calculated biometrics. The method also includes fabricating a secondary version of the mandibular repositioning device, and repeating the method as the user’s physical performance improves or the user’s biometric values change.
[0013] The predictive algorithm can include the calculated values set forth in any of the data table presented in the figures herein.
[0014] In some embodiments, the plateau of the mandibular piece has a height in a range of 8 mm to 24 mm and produces a vertical dimension of occlusion (VDO) in a range of 12 mm to 24 mm between the mandibular piece and the maxillary piece. The posterior lean angle of the protrusive flange is in a range of 4 degrees to 20 degrees from vertical. The protrusive flange has a vertical flange height measured from the cranial surface of the mandibular plane in a range of 24 mm to 36 mm.
[0015] The mandibular repositioning device further includes a lingual flange extending inferiorly and lingually from a lingual surface of the mandibular piece on each of a left side and a right side thereof, each lingual flange having a subglossal shelf depth measured from the lingual gingival margin in a range of 12 mm to 24 mm and a lingual angle measured from the lingual gingival plane in a range of 15 degrees to 60 degrees.
[0016] The method can include classifying EIAH severity of the user as mild (SaO2 nadir 93-95%), moderate (SaO2 nadir 88-93%), or severe (SaO2 nadir below 88%) from the physiologicAttorney Docket 12572.012WO1data, and generating geometry-defining parameters scaled to the classified severity. The predictive algorithm determines a minimum mouth-opening height. The training the predictive algorithm using historical physiologic data, the historical data comprising exercise-phase physiologic measurements obtained during graded exercise testing at intensities at or above lactate threshold.
[0017] In another embodiment, computer-implemented methods for generating a geometry for an oral appliance configured to improve oxygen delivery in a user are described. The method includes receiving, by a processor, physiologic, biometric, or anatomic data of the user; processing, by a predictive algorithm stored in non-transitory memory, the physiologic, biometric, or anatomic data; and outputting, by the predictive algorithm, one or more geometrydefining parameters for the oral appliance, the geometry-defining parameters comprising at least one of an anteroposterior advancement distance, a cranial-caudal repositioning distance, a volumetric repositioning value, or a mouth-opening value, wherein the geometry-defining parameters are generated to increase oxygen delivery or maintain oxygen saturation of the user during physical exertion.
[0018] The physiologic data can include oxygen saturation, partial pressure of oxygen, or lowest oxygen saturation during exercise, the biometric data comprises heart rate, resting heart rate, peak heart rate, respiratory rate, body temperature, hemoglobin concentration, age, or weight, and the anatomic data comprises airway cross-sectional area, mandibular position, tongue-base morphology, or cone-beam computed tomography measurements.
[0019] The predictive algorithm comprises one or more of a machine-learning model with a neural network, a regression model, a rules-based model, and a hybrid physiologic-mechanical model. The predictive algorithm is trained using historical physiologic data, airway imaging data, or performance data. The predictive algorithm is executed on a cloud-based server, a mobile device, or an embedded processor.
[0020] The geometry-defining parameters comprise an Effective TAVMLR value, an Effective RAP value, an anterior position at maximum mouth opening, and a predicted static open-mouth position.
[0021] The method can also include generating one or more of a predicted restored oxygen saturation value for the user during physical exertion, a predicted restored VChmax value for the user, a predicted restored DCEmax value for the user, a predicted lactate threshold value for the user, and a predicted critical power value for the user.
[0022] The method can include receiving secondary physiologic or biometric data collected while the user wears the oral appliance during physical exertion, reprocessing, by the predictiveAttorney Docket 12572.012WO1algorithm, the secondary physiologic or biometric data, and outputting, by the predictive algorithm, updated geometry-defining parameters for a second oral appliance.BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Many aspects of the disclosure can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale, emphasis instead being placed upon clearly illustrating the principles of the present system.
[0024] FIG. 1 is a left-side view of a first embodiment of a mandibular lingual repositioning device.
[0025] FIG. 2 is a left-side, perspective view of a maxillary piece of a mandibular lingual repositioning device.
[0026] FIG. 3 is a side, perspective view of the maxillary piece as it articulates and fits with the mandibular lingual repositioning device of FIG. 1.
[0027] FIG. 4 is a cross-sectional view of the mandibular lingual repositioning device along line 4-4 in FIG. 1.
[0028] FIG. 5 is front, perspective view of a controller station for use with the devices disclosed herein.
[0029] FIG. 6 is an enlarged view of the left movement mechanism of the mandibular lingual repositioning device of FIG. 1.
[0030] FIG. 7 is an enlarged view of an alternate embodiment of the left movement mechanism of the mandibular lingual repositioning device.
[0031] FIG. 8 is an enlarged side view of an embodiment of a protrusive flange.
[0032] FIG. 9 is a side, perspective view of an embodiment of a mandibular device having at least a stimulator electrode therein.
[0033] FIG. 10 is an enlarged cross-sectional view of the mandibular device along line 9-9 in FIG. 9.
[0034] FIG. 11 is a side view of an embodiment of a mandibular repositioning device that provides Dynamic Continuous Open Airway Technology (DCOAT) to the user.
[0035] FIG. 12 is a side perspective view of the mandibular piece of the mandibular repositioning device of FIG. 18.
[0036] FIG. 13 is a model comparing the movement of the mandible of a user having the mandibular repositioning device of FIG. 11 against a commercially available mandibular repositioning device.
[0037] FIG. 14 is a mathematical model of how to position and determine the convex and concave curvatures of the protrusive flange and the driver flange of a mandibular reposition device.Attorney Docket 12572.012WO1
[0038] FIG. 15 is a side view of another embodiment of a mandibular repositioning device that provides Dynamic Continuous Open Airway Technology (DCOAT) to the user.
[0039] FIG. 16 is a front view of the device of FIG. 15 in a full-open mouth position.
[0040] FIG. 17 is a right side view of a mandibular repositioning device having the protrusive flange with the convex to concave curvature described herein against the convex curvature of the driver flange.
[0041] FIG. 18 is a comparison of a sketch representative of the mandibular repositioning device of FIG. 17 (left) to a sketch (right) thereof with a mandibular plateau added to the base of the protrusive flange.
[0042] FIG. 19 is a rear view sketch of mandibular piece with the mandibular plateau of FIG.18.
[0043] FIG. 20 is a side view of an alternate embodiment for a protrusive flange having a mandibular plateau that is wedge shaped.
[0044] FIG. 21 is a side view of the embodiment of FIG. 20 with the mandibular plateau extended to the posterior surface to fill the gap shown in FIG. 20 created between mandibular piece and the maxillary piece.
[0045] FIG. 22 is a side view of a maxillary piece having a driver flange that is extended caudally, represented by the dashed lines to fill the gap shown in 27 created between mandibular piece and the maxillary piece.
[0046] FIG. 23 is a chart of plateau height and combined cranial-caudal repositioning and anterior-posterior repositioned effect.
[0047] FIG. 24 is a chart of theoretical post treatment airway dimension and oxygenation in severe and moderate OSA when using an AVMLRD disclosed herein.
[0048] FIG. 25 is a chart of actual post-treatment data using an AVMLR as compared to a BiPAP machine for a selected user.
[0049] FIG 26 is a left, side view of a first embodiment of the mandibular repositioning device having integrated anterior-posterior adjustment and cranial -caudal adjustment built into the maxillary piece.
[0050] FIG. 27 is a right, side view of a second embodiment of the mandibular repositioning device having integrated anterior-posterior adjustment and cranial -caudal adjustment built into the maxillary piece.
[0051] FIG. 28 is a right, side view of a third embodiment of the mandibular repositioning device having integrated anterior-posterior adjustment and cranial -caudal adjustment built into the maxillary piece.Attorney Docket 12572.012WO1
[0052] FIG. 29 is a side view sketch of a mandibular repositioning device having a robotically controlled and motorized adjustment mechanism built into the mandibular piece for movement of the protrusive flange and the plateau.
[0053] FIG. 30 is a flowchart of the physiological effects of increasing the size of the SMCA of a user with the mandibular repositioning devices herein.
[0054] FIG. 31 is a Table version of Algorithm I from an Excel worksheet showing the equations in the cells.
[0055] FIG. 32 is Algorithm I filled in with one example of data inputs and the corresponding calculated outputs.
[0056] FIG. 33 is a Table version of Algorithm II from an Excel worksheet showing the equations in the cells and then filled in with one example of data inputs and the corresponding calculated outputs.
[0057] FIG. 34 is a flow chart for a method of using an integrated predictive-AI algorithm to design and perfect a MRD for an individual to overcome EIAH.
[0058] FIG. 35 is a Table of prompts for inputs and the calculations for the outputs of an Integrated Predictive-AI Algorithm based on biometrics for an individual having EIAH to design a mandibular repositioning devise TAVMLR value.
[0059] FIG. 36 is a Table showing the inputs and the calculations for the outputs for Native Peak Outputs of the individual and a comparison thereof with the same variable when wearing the MRD.
[0060] FIG. 37 is a schematic block diagram of an Al-driven geometry computation flow illustrating the process from intraoral scan, data acquisition, to predictive algorithm processing and final oral appliance geometry output for EIAH mitigation.
[0061] FIG. 38 is a flowchart of an EIAH mitigation protocol showing graded EIAH severity classifications.
[0062] FIG. 39 is a graph comparing arterial oxygen saturation with and without an MRD configured to treat EIAH.
[0063] FIG. 40 is a system architecture diagram of a digital workflow platform that includes MRD prescription management, digital impression handling, Al-geometry computation, fabrication routing, outcome aggregation, and clinician education modules.
[0064] FIG. 41 is a screenshot from a dynamic modeling software program that enables the adjustment of a plurality of parameters of the MRD configured to treat EIAH.DETAILED DESCRIPTION
[0065] Subject matter will now be described more fully hereinafter with reference to the accompanying drawings, which form a part hereof, and which show, by way of illustration,Attorney Docket 12572.012WO1specific example embodiments. Subject matter may, however, be embodied in a variety of different forms and, therefore, covered or claimed subject matter is intended to be construed as not being limited to any example embodiments set forth herein; example embodiments are provided merely to be illustrative. Likewise, a reasonably broad scope for claimed or covered subject matter is intended. Among other issues, subject matter may be embodied as methods, devices, components, or systems. The following detailed description is, therefore, not intended to be interpreted in a limiting sense. In the drawings, reference numbers indicate identical or functionally similar elements. The embodiments are non-limiting and may be combined, modified, or substituted without departing from the scope of the invention.
[0066] Throughout the specification and claims, terms may have nuanced meanings suggested or implied in context beyond an explicitly stated meaning. Likewise, phrases such as “in one embodiment” or “in an example embodiment” and variations thereof as utilized herein may not necessarily refer to the same embodiment and the phrase “in another embodiment” or “in another example embodiment” and variations thereof as utilized herein may or may not necessarily refer to a different embodiment. It is intended that claimed subject matter include combinations of example embodiments in whole or in part.
[0067] As used herein, the term “about” in relation to any measurable variable, such as angles, lengths, widths, etc., standard rules of significant figures and instrument measurement limitations are applicable.
[0068] As used herein, mandibular repositioning device (MRD) is the shorthand for all embodiments of oral appliances disclosed herein, including without limitation mandibular lingual repositioning devices (MLRDs), antero-vertical mandibular-lingual repositioning devices (AVMLRDs), and total antero-vertical mandibular-lingual repositioning (TAVMLRDs), and all variations and combinations thereof.
[0069] As used herein, the following terms have the specified meanings.“EIAH” means Exercised Induces Arterial Hypoxemia, which is a reduction in arterial oxygen saturation (SaCh) below 95% at maximal exertion, or an alveolar-to-arterial oxygen partial pressure difference (A-aDCh) exceeding 25 Torr. EIAH severity is classified as mild (SaCh 93-95%), moderate (SaCh 88-93%), or severe (SaCh less than 88%)."TAVMLR" means Total Antero-Vertical Mandibular-Lingual Repositioning and represents the volumetric displacement of mandibular and lingual structures, measured in cubic millimeters."RAP" means Required Advancement Position and represents the optimal anteroposterior mandibular advancement distance, measured in millimeters.Attorney Docket 12572.012WO1"MxMO" means anterior position at Maximum Mouth Opening, measured in millimeters."LSAT" means Lowest Oxygen Saturation recorded during exercise testing."SMCA" means Smallest Concentric Airway Cross-Sectional Area."DCOAT" means Dynamic Connected-Arc-of-Motion Technology.“Airway Throttle Body” means the hyoid bone and reflects its function as the biomechanical control point that regulates the cross-sectional area of the retrolingual airway. This designation draws a functional analogy to the throttle body of an internal combustion engine: just as a throttle body governs the volume and velocity of airflow entering the engine's intake manifold, the hyoid bone governs the volume and velocity of airflow through the pharyngeal airway. The hyoid bone is the only bone in the human body that is not articulated with any other bone. Suspended by the suprahyoid and infrahyoid muscle complex and attached to the styloid process via the stylohyoid ligament, the hyoid serves as the primary skeletal anchor for the tongue musculature — including the hyoglossus, geniohyoid, and mylohyoid muscles — and plays a critical role in governing the caliber of the retrolingual airway.
[0070] The mandibular repositioning device and system herein is configured to provide antero-superior displacement of the hyoid bone, which enlarges the retrolingual space, reduces pharyngeal collapsibility (increasing the critical closing pressure (Pcrit) toward more negative values), and promotes laminar airflow through the pharyngeal airway. This biomechanical effect has been recognized in hyoid suspension surgery, such as a hyoidothyroidopexy and a hyoidomandibulopexy These surgeries require general anesthesia, permanent suture fixation of the hyoid body to the mandible or thyroid cartilage, and typical surgical risks including infection, hemorrhage, dysphagia, and unsatisfactory cosmetic outcomes. The mandibular repositioning device and system disclosed herein achieves comparable antero-superior Airway Throttle Body displacement through a non-surgical, removable, titratable, Al-personalized oral appliance mechanism.
[0071] Mandibular advancement mechanically transmits force through the genioglossus and geniohyoid muscles, which originate on the genial tubercles of the mandibular symphysis and insert on the tongue body and hyoid bone, respectively to effect antero-superior displacement of the Airway Throttle Body. The lingual repositioning geometry of the present invention augments this effect by directly engaging the ventral tongue surface and lateral tongue borders, thereby inducing anterior displacement of the tongue base and further tensioning the genioglossus-geniohyoid muscular chain. The cooperative biomechanical effect of mandibular advancement and lingual repositioning produces Airway Throttle Body displacement that exceeds what is achievable by either mechanism alone.Attorney Docket 12572.012WO1
[0072] Referring to FIG. 34, a method is shown and described that includes determining a user’s exercise induced arterial hypoxia (EIAH) value , inputting the user’s EIAH value and biological data or values into a predictive algorithm stored in nontransitory memory of a microprocessor, outputting, via the predictive algorithm, a flange geometry and other flange or oral appliance related parameters for a mandibular repositioning device configured to restore the user’s partial pressure oxygen value (PaCh) to at least a rest level or increase oxygen delivery, especially during physical exertion, and fabricating the mandibular repositioning device with the flange geometry. Biological data can include any one or more of a user’s various physiological data, biometric data, and anatomical data. More specifically, the integrated predictive-AI algorithm outputs, as an example of some of the flange geometry or other flange or oral appliance parameters, (i) an Effective TAVMLR value (typically in cubic mm), which can include an anteroposterior advancement distance, a cranial -caudal repositioning distance, a volumetric repositioning value, and a mouth-opening value, (ii) an Effective RAP (in mm), (iii) an anterior position at maximum mouth opening (MxMO) in mm, and (iv) a predicted static open-mouth position where the appliance geometry is optimized for stable airway displacement during physical exertion, which instruct the MRD manufacture on how to build the flange geometry. The parameters of the Effective TAVMLR define the three-dimensional repositioning of mandibular and lingual structures necessary to restore arterial oxygenation during exercise. The Effective RAP specifies the optimal anteroposterior mandibular advancement distance. Part of determining a user’s EIAH is identifying a user that experiences a drop of greater than 4-5% of their PaCh. This is too significant a drop in PaC>2 and needs improvement because it is an indication that their peak performance is being limited by a lack of oxygen.
[0073] The biological data of the user that is input into the algorithm can include physiological data such, but not limited to, as oxygen saturation (SpCh). partial pressure of arterial oxygen (PaCh). lowest O2 saturation (LSAT) during exercise, and hear rate (resting and / or peak). The system may also receive alveolar-to-arterial PO2 difference (A-aDCh) measurements, exercise-induced desaturation profiles obtained during graded exercise testing (GXT) with continuous pulse oximetry, and the SaCh nadir and desaturation onset point. These physiological data points can be measured without an MRD, pre-MRD stage, at a resting O2 stage, at peak a heart rate, or as determined by a clinician. These physiological data points can also be used to quantify the severity and timing of EIAH in the individual and are obtained during an EIAH mitigation protocol as set forth herein.
[0074] The biological data of the user that is input into the algorithm can include biometric data such as, but not limited to, body temperature, respiratory rate, hemoglobin count in gm / dl, age, and weight, but is not limited thereto. These parameters provide context for individualAttorney Docket 12572.012WO1variations in oxygen carrying capacity, metabolic demand, and ventilatory response during maximal exertion.
[0075] The anatomic data of the user that is input into the algorithm can include, but is not limited to, airway cross-sectional area, mandibular position, tongue-base morphology, and conebeam computed tomography (CBCT) measurements. Specifically, the anatomic data comprises the smallest concentric airway cross-sectional area (SMCA) measured in the retropalatal and retrolingual segments, mandibular protrusion distance, pharyngeal airway length and volume, and tongue volume. Key craniofacial landmarks identified from the CBCT data include Point A, Point B, nasion, sella, gonion, menton, and the hyoid bone position. Cephalometric analysis yields the ANB angle, mandibular plane angle, and hyoid-to-mandibular-plane (H-MP) distance, all of which inform the predictive algorithm. Identification and measurement of these landmarks is explained in Boccalari et al., The Maxillomandibular Sagittal Assessment: The ABwise Appraisal and Its Correlation with ANB Angle, J. Clin. Med., 2025, 14, 1379.
[0076] Prior to processing by the predictive algorithm, the biological data undergo feature extraction and preprocessing, including a normalization step. The system normalizes all input data into standardized feature vectors, handles missing values through imputation, detects and manages outliers, and applies dimensionality reduction where appropriate. For anatomic data, a convolutional neural network (CNN) landmark identification module identifies craniofacial landmarks from three-dimensional point cloud data obtained during intraoral scanning. The scanner captures the dentition and surrounding soft tissue structures at a resolution of at least 50 microns using structured-light or laser scanning technology. The resulting point cloud is converted to a mesh and exported in STL, PLY, OBJ, or STEP format for downstream processing.
[0077] The predictive algorithm, which is stored in non-transitory memory, comprises, in a preferred embodiment, a machine-learning model. The machine -learning model may comprise a deep neural network trained on three-dimensional point cloud data from prior patient dentitions and their treatment outcomes. The neural network processes the normalized feature vector and generates the geometry-defining parameters for the oral appliance configured to mitigate exercise-induced arterial hypoxemia. In alternative embodiments, the predictive algorithm comprises a regression model, a rules-based model encoding clinical expertise, or a hybrid physiologic-mechanical model. The hybrid model integrates physiologic variables (oxygen saturation response curves, ventilatory parameters, hemoglobin-oxygen dissociation characteristics) with mechanical variables (airway tissue compliance, pharyngeal wall stiffness, tongue-base mass) to simultaneously optimize oxygen delivery restoration and biomechanical feasibility of the oral appliance geometry.Attorney Docket 12572.012WO1
[0078] The predictive algorithm is trained using historical physiologic data, airway imaging data, and performance data from patients who underwent mandibular-lingual repositioning therapy for mitigating exercise-induced arterial hypoxemia. Training features include pretreatment airway dimensions, mandibular protrusion distances, post-treatment oxygen saturation during maximal exertion, changes in maximal oxygen consumption (VCfmax). and patient-reported performance outcomes. The model employs supervised learning and continuously refines its predictions as new patient outcome data accumulates. A cephalometric analysis module processes CBCT data to extract the ANB angle, mandibular plane angle, and H-MP distance for integration into the training pipeline.
[0079] The predictive algorithm also includes a cephalometric analysis module for processing CBCT data to extract the ANB angle, mandibular plane angle, and H-MP distance for integration into the calculations and / or training of the Al model.
[0080] The fabricating of the mandibular repositioning device can include 3-D printing such as 3D stereolithography (SLA) printing and / or 3D SLA dry printing. The oral appliances should be made of FDA approved materials suitable for use in the oral cavity of a user. These can be molded from such materials, 3-D printed from such materials, or formed therefrom using any FDA approved methods. The materials can include metals and metal resins. Regular 3D SLA printing is useful for all types of devices (nighttime, daytime, and physical activity). The 3D SLA dry printing with metal and metal resins is useful for oral appliances intended for use during physical activities. It can be used with all three devices as well using a combination of both types of printing.
[0081] In another embodiment, the oral appliances can be manufactured using a milling method. Also, the oral appliances can be manufactured in layers and then assembled or built simultaneously and fused or affixed together. Layering techniques can be useful when sensors, transmitters, receptors, circuit boards, PIC, OCUBIT, CUBIT, etc. are present in the oral appliance. Another method that can be used to make the oral appliances is robotic CNC subtractive manufacturing. This can be used for any of the oral appliances.
[0082] In one embodiment, the MRD is as disclosed in U.S. Application No. 17 / 098,335 and U.S. Application No. 17 / 366,421. It has a maxillary piece that has a driver flange protruding laterally outward on either or both of the right side and left side thereof, and each driver flange has an anterior side with a convex curvature. The mandibular piece has a protrusive flange extending cranially therefrom positioned to have a posterior side engaged with the anterior side of the driver flange, and the posterior side of each protrusive flange has a concave-to-convex curvature from a base of the protrusive flange toward a most cranial point of the protrusive flange. The convex portion of the concave-to convex curvature engages the convex curvature ofAttorney Docket 12572.012WO1the driver flange in a rest position. The MRD can also include a plateau of a preselected height between a base of the protrusive flange and the mandibular piece.
[0083] In another embodiment, the MRD is as disclosed in U.S. provisional Application No.63 / 802,715, filed the same day as this application’s priority document. It has a mandibular piece that has a platform along a superior occlusal surface that defines a first ramped surface with a rise oriented anteriorly and a first flange extending cranially upward from an anterior end of the platform, wherein the posterior side of the first flange is oriented at a posterior lean in a range of 3 to 20 degrees relative to the superior occlusal surface and contoured as a (i) concave curvature or (ii) a concave -to-convex surface in the caudal to cranial direction. The maxillary piece has a second flange that extends caudally downward from an inferior occlusal surface thereof. In a rest position, the second flange has a caudal side shaped to seatingly mate to the platform of the mandibular piece and an anterior side with an opposite surface contour shaped to seatingly mate to the posterior side of the first flange, thereby defining a wedge-shaped column having its rise defined by the height of the first flange separating the mandibular piece from the maxillary piece and defining a static open mouth position. The static open mouth position is configured to maintain a user’s oxygen concentration in the bloodstream at a pre-selected concentration, and downward movement of the mandibular piece moves the posterior side of the first flange along and in contact with the anterior surface of the second flange for gradual incremental forward mandibular movement, which increases the cross-sectional area of the user’s airway.
[0084] Still referring to FIG. 34, the method can include a validating process. The validating process is an evidence -based outcome to gather / measure the user’s secondary biometrics while wearing the mandibular repositioning device with the flange geometry output by the integrated predictive-AI algorithm. The method also includes inputting the secondary biological data into the predictive algorithm, having the CPU process the data in the integrated predictive-AI algorithm and outputting calculated biometrics, the calculated biometrics are assessed and if warranted, fabricating a secondary version of the mandibular repositioning device.
[0085] The method can be repeated as many times as needed to achieve a desired performance for the user, i.e., their physical performance in the respective activity improves. The improved performance may be speed, endurance, strength, etc. The physical activity can be any sport, and the validation can include pushing the user to a peak performance level during the activity with the MRD. The validation includes monitoring the user’s biometrics during physical activity, including any and all of the parameters included in FIGS. 35 and 36. Some of the biometrics include critical power (CP), lactate threshold (LT), VCUmax, DCUmax, and others. The validation portion of the process can be repeated as many times as needed, especially as the user’s performance during the physical activity improves.Attorney Docket 12572.012WO1
[0086] As shown in FIG. 36, the integrated predictive-AI algorithm calculates a plurality of values, including A(DO2max-VO2max), rVC>2max, rD02inax and AirDChmax-rVChmax). As the user’s performance improves, the validation process can be rerun to determine if it is time to change the MRD for additional improvement in performance.
[0087] The MRD may be constructed as an AIO BRUT™ MRD with the customized flange geometry output by the integrated predictive-AI algorithm. The AIO BRUT brand MRD is an oral appliance made of two trays (upper and lower) which fit over the teeth. Due to the accuracy of the fit, there may be click as it sockets securely in place. The protrusive flanges should touch and slide lightly against each other as the mouth opens and closes. The tongue will be physically repositioned and supported by the appliance in a slightly forward position. The AIO BRUT™ MRD when worn while clenching teeth will still allow for mouth breathing when the lips are not covering the teeth. The AIO BRUT ™ MRD sports a light, durable form to protect and maximize comfort. The flanges create a CONNECTED -ARC-OF-MOTION ™ which allows for an open airway at all angles of mouth open and close. As verified by cone beam computed tomography, a human airway with an MRD as compared to without an MRD has starkly evident differences in the cross-sectional area of the human airway. By increasing the cross-sectional area of the airway, air-flow resistance is reduced. Reduction of air-flow resistance has been shown to increase the total amount of O2 intake per breath, allowing for more oxygen delivery. This means more oxygen supply at a given heart rate, allowing the individual to perform at higher intensity for a longer period.
[0088] With general reference to FIG. 37, the Al-driven geometry computation pipeline receives data from multiple sources (i.e., inputs) and processes it through a series of computational stages to generate oral appliance geometry for EIAH mitigation. The pipeline comprises four principal stages: (a) data ingestion, (b) feature extraction and preprocessing, (c) predictive algorithm processing, and (d) geometry output. All stages execute on a processor in operative communication with non-transitory memory storing the predictive algorithm. This schematic representation of the method includes an intraoral scan or image acquisition model, which can include 3D scans or images such as CBCT scans or other known or herein after developed oral / dental scanning techniques. The scan or images are then processed through a digital model import and meshing processor, which sends data to an anatomical landmark detection engine. This data, along with clinical data entered at a clinical data input interface, is processed through a predictive algorithm stored in nontransitory memory of a computer processor, which computationally cooperates with a geometry computational model to output parameters for the flanges and other features of an MRD. The output parameters can include a RAP value, a RVP value, a TAVMLR value, and the millimeters for maximum mandibularAttorney Docket 12572.012WO1advancement and for vertical advancement of the hyoid bone. The clinical data can include any of the variables noted in FIGS. 30-36. The method outputs a digital design for the MRD appliance and CAD and / or CAM fabrication routing to be sent to an appropriate manufacturing machine, system, or platform.
[0089] Beyond geometry-defining parameters, the predictive algorithm generates performance -prediction outputs specifically designed to assess EIAH mitigation effectiveness. These include a predicted restored oxygen saturation (SaOz) value during maximal exertion, representing the expected arterial oxygen saturation after the oral appliance achieves the computed repositioning geometry. The predictive algorithm further generates a predicted restored VChmax value representing the expected maximal oxygen consumption after restoration of arterial oxygenation, and a predicted restored DChmax value representing the expected maximal oxygen delivery (the product of cardiac output and arterial oxygen content) after restoration. The predictive algorithm additionally generates a predicted lactate threshold value representing the expected exercise intensity at which blood lactate accumulation is delayed due to restored oxygen delivery, and a predicted critical power value representing the expected sustainable power output at restored arterial oxygenation. These performance -prediction outputs allow clinicians and athletes to quantify the physiologic benefits of the oral appliance before fabrication and establish benchmarks for post-fitting verification.
[0090] The integrated predictive-AI algorithm utilize the variables and equations described above and in one example shown in FIGS. 35 and 36, which provides the numerical values showing in Tables 1-3 of the below working example.WORKING EXAMPLETable 1EFFECTIVE TAVMLR / RAP FORMULA: DESIRED SaOz%(EXERCISE & SLEEP RECOVERY)Lowest SaOz% Minimum Mouth Open Desired SaOz%(ISaOz) (MnMO°) 89 98 8Anterior position at Effective TAVMLR Effective RAP M2MO(mm3) (mm) (mm) 11 8 23 PREDICTED O2 SAT FROM PRESELCTED TAVM] LR AND LSAT FOR EXERCISE OR SLEEP RECOVEF LYLowest SaOz% Pre-selected TAVMLR Restored SaOz% (lSaO2EXERCISE) (mm3) (rSaO2best VO2 max)89 6 945 93Atorney Docket 12572.012WO14 92 7 95 8 96 9 96 OBSERVED BIOMETRIC INPUTS THAT DRIVE pExercise outputs BIOMETRICS MALE FEMALE AGE (in years) 25 25 Weight in lbs 155 112 Hemoglobin (gm / dl) 15 13.5 Resting Heart Rate (Actual) 54 55 pHeart rate at ISaOz (Actual) 165 179pHR at pExercise at rVOzmax 155 149 Table 2VOzmax Consumption mL / Kg / min i Age dependent v / s Actual) PEAK OUTPUTS (NATIVE) MALE FEMALE AGE (in years) 25 25 Peak Heart Rate (age dependent) 195 195 Resting Heart Rate (Actual) 54 55 Max Heart Rate (Actual exercise) 165 179 VOzmax Consumption (Peak HR) 55.25 40.68 VOzmax Consumption (Max HR) 46.75 37.35 Lactate Threshold (LR) %VOzmax 38.80 31.74 Critical Power Relative (CPR) 35.06 28.01Critical Power Absolute (CPA) 39.74 31.74 Table 3DOzmax ml / Kg / min; VOzmax ml / Kg / min at peak exercise (pExercise) COMPARISON NATIVE / AIO DEVICES MALE FEMALE ISaOz during exercise native 89 89 pHeart rate at ISaOz 165 179 IVOz max consump at ISaOz / pHR 46.75 37.35 Hemoglobin gm / dl 15 13.5 Weight in lbs 155 112 Cardiac Stroke Volume (avg) 89.75 69.32 DOzmax (Delivered Oz) ml / kg / min 61.89 64.23 rSaOz during exercise (%) AIO 94 94 A(DOzm ax- VOzm ax) 15.14 26.89 pHR at pExercise at rVOzmax 155 149 rVOzmax consumption (pHR) 43.92 31.09 rDOzmax (Delivered Oz) ml / kg / min 61.40 56.65 A(rDOzmax-rVOzmax) 17.49 25.56Restored Lactate Threshold (rLR) %VOzmax 36.45 25.80Attorney Docket 12572.012WO1Restored Critical Power Relative (rCPR) 32.94 23.32Restored Critical Power Absolute (rCPA) 37.33 26.43
[0091] The Restored Lactate Threshold (rLR) %VC>2max is calculated by multiplying the rVOanax consumption (pHR) *0.83. The Restored Critical Power Relative (rCPR) is calculated by multiplying the rVChmax consumption (pHR) *0.75. The Restored Critical Power Absolute (rCPA) is calculated by multiplying the rVChmax consumption (pHR) *0.85.
[0092] A second example of calculated values for a male and a female user that have a ISaCh during exercise native of 92 and a pHeart rate at ISaCh of 170 is shown below.Table 4DChmax ml / Kg / min; VChmax ml / Kg / min at peak exercise (p Lxercise) COMPARISON NATIVE / AIO DEVICES MALE FEMALE ISaOz during exercise native 92 92pHeart rate at ISaOz 170 170IVO2 max consump at ISaOi / pHR 48.17 35.32 Hemoglobin gm / dl 15 13.5 Weight in lbs 155 112 Cardiac Stroke Volume (avg) 89.75 69.32 DOimax (Delivered O2) ml / kg / min 65.88 63.14rSaO2 during exercise (%) AIO 98 98A(DO2m ax- VO2m ax) 17.71 27.82pHR at pExercise at rVO2max 159 159 rVO2max consumption (pHR) 45.05 33.02 rDO2max (Delivered O2) ml / kg / min 65.52 62.82 A(rDO2m ax- r V 02m ax) 20.47 29.79 Restored Lactate Threshold (rLR) %VO2max 37.39 27.41 Restored Critical Power Relative (rCPR) 33.79 24.77Restored Critical Power Absolute (rCPA) 38.29 28.07
[0093] The system implements adaptive optimization through closed-loop reprocessing. After initial fitting of the oral appliance based on the first-pass geometry-defining parameters, the system receives secondary physiologic or biometric data collected while the user wears the oral appliance during exercise. This secondary data includes real-time SpCL. heart rate, respiratory rate, and airflow measurements obtained from integrated or external sensors.
[0094] The predictive algorithm reprocesses the secondary physiologic or biometric data to evaluate whether the current oral appliance geometry achieves the target oxygen deliveryAttorney Docket 12572.012WO1restoration for mitigating exercise-induced arterial hypoxemia. Based on the reprocessing, the predictive algorithm outputs updated geometry-defining parameters for a second oral appliance. The updated parameters optimize the TAVMLR, RAP, and MxMO values based on the actual physiologic response measured during exercise. This iterative cycle of measurement, reprocessing, and geometry refinement progressively aligns predicted outcomes with measured in-exercise performance.
[0095] The predictive algorithm may be executed on a cloud-based server, a mobile device, or an embedded processor. In the cloud-based embodiment, the predictive algorithm executes within a digital workflow platform, such as the example presented in FIG. 40, which provides prescription management, digital impression handling, Al geometry computation, fabrication routing, outcome aggregation, and clinician education modules. Role-based access controls ensure HIPAA and GDPR compliance.
[0096] In the mobile embodiment, a lightweight inference model derived from the trained algorithm executes on a companion application for real-time optimization during exercise. In the embedded embodiment, the algorithm executes directly on a processor within the oral appliance or a wearable device for low-latency edge processing during physical exertion.
[0097] Referring to FIG. 38, the EIAH mitigation protocol starts at identification of a patient or individual suspected of having EIAH and conducting a baseline resting assessment thereof. Following the baseline, the testing begins with graded exercise testing (GXT) with continuous pulse oximetry monitoring and, in preferred embodiments, arterial blood gas sampling at peak exertion and options post-exertion. The protocol evaluates the individual based on their SaCE drop. If the SaCE drop is greater than or equal to 3-4% below their baseline, a diagnosis of EIAH is “Yes”, which them classifies the EIAH severity. The EIAH severity is based on the SaCE nadir: mild (93-95%), moderate (88-93%), or severe (less than 88%). The physiologic data captured during the GXT, including the SaCX nadir, desaturation onset point, peak A-aDCE, and temporal desaturation profile, are received by the Al-driven geometry computation module for processing and determining flange geometries and other parameters for the MRD. The predictive algorithm computes mandibular-lingual repositioning geometry designed to restore SaCX to at least 95% during maximal exertion by optimizing Airway Throttle Body (hyoid bone) displacement and reducing upper airway resistance. Referring to FIG. 39, verification testing after oral appliance fitting, shown as a line graph comparing before (no MRD) and after (with the Al-generated MRD design) confirms that the system restores arterial oxygen saturation above the EIAH threshold during exercise at equivalent or greater intensity than the diagnostic GXT.
[0098] Per the EIAH mitigation protocol of FIG. 38, after the graded exercise testing with the MRD in situ, if the SaCX is restored to at least 95% during exertion, outcome data from theAttorney Docket 12572.012WO1testing is recorded, such as post-AHI, SaC>2 restoration, and device parameters. Additionally, the protocol runs a self-learning regression and updates Al-leaming modules. In one embodiment, the self-learning implements the equation: Post_AHI = 1.7722 + 0.0155 x pre_AHI as well as a slope, intercept, and RSQ recalculation. The protocol can also include ongoing monitoring of the individual and / or periodic re-assessment of the individual.
[0099] Per the EIAH mitigation protocol of FIG. 38, if the SaCh is not restored to at least 95% during exertion, titration adjustments are made and the process is repeated from the appropriate point in the protocol.
[0100] The predictive algorithm described herein represents a departure from prior devicedesign algorithms, which have focused exclusively on sleep apnea metrics such as the apnea-hypopnea index (AHI) and oxygen desaturation index (ODI) during sleep. The present algorithm processes exercise-specific physiologic inputs, including VCEmax, lactate threshold, critical power, and exercise-induced desaturation profiles, and generates oral appliance geometry optimized for dynamic airway stability during the high ventilatory demands of maximal physical exertion. The predictive algorithm classifies EIAH severity from the input physiologic data and generates geometry-defining parameters scaled to the severity classification. Mild EIAH (SaCh nadir 93-95%) is addressed with a first parameter set comprising a posterior lean angle in a lower sub-range of 4-10 degrees, a plateau height of 8-14 mm, and a VDO of 12-16 mm. Moderate EIAH (SaCh nadir 88-93%) is addressed with a second parameter set comprising a posterior lean angle in a mid sub-range of 10-16 degrees, a plateau height of 14-20 mm, and a VDO of 16-20 mm. Severe EIAH (SaO2 nadir below 88%) is addressed with a third parameter set comprising a posterior lean angle in an upper sub-range of 16-20 degrees, a plateau height of 20-24 mm, and a VDO of 20-24 mm. The EIAH-specific training data used to train the predictive algorithm comprises exercise-phase physiologic measurements obtained during graded exercise testing at intensities at or above lactate threshold, and is distinguished from sleep-phase training data based on apnea-hypopnea index (AHI) or oxygen desaturation index (ODI) during sleep.
[0101] Some additional advantages of the devices and system disclosed herein include, since the MRD is worn during exertions and / or athletic activities, if the individual experiences a concussion, the MRD keeps the mandible and tongue advanced forward to prevent the airway from closing, thereby protecting the individual from concussion-related oxygen deprivation. The MRD can also be worn at night to maintain oxygen delivery while asleep. This can provide improved sleep quality and better mental and physical recovery after athletic training.
[0102] Referring now to FIGS. 1 to 4, a mandibular lingual repositioning device (MLRD) that is dynamic in its movement of the jaw(s) and tongue is represented collectively in FIG. 3 byAttorney Docket 12572.012WO1reference number 100. The MLRD 100 has a maxillary piece 102 seated on a mandibular piece 104 for operative communication of drivers built therein.
[0103] Turning to FIGS. 1 and 4, the mandibular piece 104 is shown, which has a first teeth covering 106 and has a housing 108 proximate each of a left molar portion 110 and a right molar portion 112. A protrusive flange 114 extends cranially from each housing 108, and a stimulator 116 extends from each housing 108 toward the tongue at a position to lie under the tongue in contact with lingual muscles, in particular the Genioglossus (GG), the Geniohyoid (GH), sub-mentalis (SM), and Glossopharyngeal (GP) muscles. The stimulator protrusion 116 of each housing 108 should be fitted to the user / custom made for the user to ensure proper contact with the lingual muscles. Each stimulator portion 116 while appearing somewhat boxy-looking in the drawings, is more preferably molded of moldable material suitable for use in a human oral cavity and has smooth transitions to its shape and is shaped to match the shape of the user’s mouth, especially to sit under the tongue in contact with the base of the tongue and the floor of the mouth as shown in FIG. 4. The stimulator may extend into a flexible soft, continuous stretch of material that extends from the lingual caudal edge of the mandibular piece wrapping around to the left and right molar region and gently lays on the floor of the mouth and around the base of the tongue in close contact with the genioglossus and geniohyoid muscles that originates at the caudal sub-mental surface of the mandible. Electrical stimulation of the entire floor of the oral cavity through the stimulator will create contraction of these muscles thus facilitating the entire bulk of the posterior aspect of the tongue to be pulled anteriorly, the floor of the mouth pulled cranially, the hyoid bone pulled anteriorly and lifted cranially while pulling the lateral walls of the SMCA laterally. This movement widens the antero-posterior and lateral diameters of SMCA while shortening the entire length of the airway tube in the vertical dimension.
[0104] The moldable material may be any of those commercially available or hereinafter developed for use in a human oral cavity. The moldable material can be shaped and sized to fit the entire tongue like a glove or sock. It may also retain the tongue in its awake position thereby preventing it from falling back passively into the airway while asleep whilst still allowing voluntary movements of the tongue such as involved in speech and swallowing. The moldable material could also extend from the molar left side all the way to the front and then to the right side, thus fitting like a horse-shoe around the base of the tongue so as to evenly electrify all components of the muscles it comes in contact with when an electrical stimulator is present.
[0105] Referring now to the transverse cross-section of FIG. 4, each housing 108 encloses, in a fluid-tight manner, a power source 120 electrically connected to a motor 122, to a circuit board 124, and to the stimulator 116. A first driver 130 is operatively connected to each motor 122 for cranial to caudal adjustments of the device 100. The first driver 130 is linearly translatable byAttorney Docket 12572.012WO1linkages 134 operatively connected to the motor 122 within its housing 108 as shown in FIG. 3. The linkages 134 will be fluid -proof, heat-resistant and acid-resistant and thus able to withstand the conditions found within the oral cavity of a user.
[0106] With reference to FIGS. 2 and 3, the maxillary piece 102 is shown, which has a second teeth covering 107 and has a housing 109 proximate each of a left molar portion 111 and a right molar portion 113. Referring to the partial cross-sectional view of FIG. 3, each housing 109 encloses a power source 121 electrically connected to a motor 123 and to a circuit board 125. A second driver 132 is operatively connected to each motor 123 for anterior to posterior adjustments of the device 100. The second driver 132 is linearly translatable by linkages 135 operatively connected to the motor 123 within its housing 109.
[0107] In all embodiments, the housings 108 and 109 may be fixedly attached to the respective teeth covering, integral therewith, or removable attachable thereto. When removable attachable, the housings 108, 109 may be slid over a molar portion of the teeth covering, have a snap fit thereto, an interference fit thereto, may be a two-piece compartment that snaps together over a predetermined location of the teeth covering, may be three-dimensionally printed to cover or fit over a portion of the teeth covering. In all embodiments, while the teeth coverings 106, 107 are shown as full coverings for all teeth in the mandible and all teeth in the maxilla, the teeth coverings are not limited thereto. Instead, each teeth covering may be a partial cover for one or more teeth, as such, the mandibular piece 104 may be a two-part configuration having a left and a right portion each with a housing 108 and the maxillary piece 102 may be a two-part configuration having a left and a right portion each with a housing 109.
[0108] In all embodiments herein, each housing 108, 109 is described herein as positioned proximate a molar portion of a teeth covering, but is not limited to any particular size, i.e., the number of teeth to which it is associated. Each housing may be associated with one tooth region, a two-tooth region, a three-tooth region, or whatever number of teeth is needed to accommodate the size and position of the housing and its stimulator protrusion.
[0109] Referring to FIGS. 1, 3, and 4, the protrusive flange 114 of the mandibular piece 104 is an elongate flange that is releasably, removably attached to or may be integral with the housing 108. A releasably, removably attachable protrusive flange 114 is shown in FIGS. 6 and 7 to accommodate an interchangeability of protrusive flanges 114 of different shapes and sizes to provide the best fit for the user’s mouth. In the embodiment of FIG. 1, the protrusive flanges 114 are generally an elongate linear flange protruding cranially from each of the housing 108. The protrusive flange 114 may be a housing containing within an antenna, a receiver-transmitter for two-way communication, an infrared homing or signaling device, a unique signature emittingAttorney Docket 12572.012WO1device, an encoder or a multi-polarity magnetic clasp that facilitates coordinated movements with the second driver 132 with which the protrusive flange 114 articulates.
[0110] Turning now to FIGS. 6 and 7, the protrusive flange 114' is releasably attachable to the housing 108 of the mandibular piece 104. The protrusive flange terminates with a post 144 opposite a free end 142 thereof. The post 142 includes a releasably attachable feature 146, such as a snap fit feature, a friction fit feature, or threaded holes as shown in FIG. 7. The housing 108 defines a receptacle 126 shaped to receive the post 144. The receptacle 126 will have a releasably attachable mating feature 128 that mates with the releasably attachable feature 146 of the post 144. In FIG. 7, the releasably attachable mating feature 128 is a set of threaded holes and screws 129.
[0111] As shown in FIGS. 6 and 7, the protrusive flange 114' can have a bend 140 on the anterior side of the flange, but this is not required. The new feature in this embodiment is that the posterior side 145 of the protrusive flange 114' is arcuately shaped as best shown in FIG. 8 as a concave surface, which mates with a driver 132 having a convex surface shaped to match the concavity of the posterior side 145. The protrusive flange 114 or 114’ and its post 144 may lean posteriorly at any angle that may suit the need of a particular user. The midpoint 147, relative to being the middle or halfway point between the free end 142 and the opposing end 143, of the arcuately shaped posterior side 145 defines an arc of a circle having its center at the temporomandibular joint (TMJ) in this illustration and the free end 142 has a width that is smaller than a width of the opposing end 143 of the flange. The arc of the circle is one that defines 0i as being any angle with the range of 12 degrees to 15 degrees in increments of whole degrees, half degree, or 0.2 degree increments. The angle of the arc 0i defines the amount of protrusion of the mandible with each degree of mouth opening. The larger this angle 0i, the greater the protrusion with mouth opening. The larger the angle of mouth opening, the larger the protrusion of the mandible. Furthermore, a strong correlation between mandible movement and Apnea / Hypopnea events has been shown in the literature. Increased respiratory effort (due to OSA) is associated with increased mandibular movements and mouth opening. Data shows 98% (n=33) of open mouthing and large mandibular movement of 99.6% (n=33) were observed in OSA patients (children) who were confirmed to have OSA by polysomnography. “Mandibular movements were predominantly a change in position during increased upper airway resistance during the respiratory cycle as exhibited by mandibular lowering and jaw opening”. Mandibular Movements Identify Respiratory Effort in Pediatric Obstructive Sleep Apnea (aasm.org). “The mandible is the anchor for upper airway muscles that dilate and elongate the pharynx and its position determines mouth opening. In OSA, the mandible lowers to a greater degree than inAttorney Docket 12572.012WO1normal sleep due to activation of the upper airway muscles allowing traction on hyoid bone and mouth opening to facilitate mouth breathing”.
[0112] The arcuate surface is customizable to provide a curvature that provides the best forward movement of the mandible for the user in relation to the individual user’s mouth shape and size. Depending upon the shape and size of the user’s mouth and jaws, the radius defining the point of the arc may be offset by moving this point up or down relative to the midpoint 147, which may change the widths of the free end 142 and the opposing end 143.
[0113] The advantage to the arcuately shaped side 145 of the protrusive flange 114' is that it will help protrude the mandible forward as the Temporo-Mandibular joint (TMJ) relaxes and the mouth falls open during sleep, wake or any other transitional state of the human mind (such as various Parasomnia create) thus allowing gradual smooth arcuate incremental forward mandibular movement to occur as concave surface 145 of protrusive flange 114' smoothly glides against convex surface 136 of driver 132'. The maximum protrusive distance (MPD) for anterior movement of the mandible is in a range of 0 mm to 15mm, more typically 6 mm to 10 mm. Typically, the first 13 degrees of rotation of the mandible about the TMJ during natural, un-aided spontaneous mouth opening does not move the mandible anteriorly, i.e., this rotation does not change or open the airway. Drivers 130, 132 will actively coordinate simultaneous desired amount of vertical and protrusive movements of the mandible (controlled by controller) during this first 13 degrees of mouth opening while the arcuate opposing gliding movements of concave surface 145 of protrusive flange 114' smoothly against convex surface 136 of driver 132'surfaces will passively create mild forward movement of the mandible and tongue away from the airway, thus increasing the size of the airway. Driver 132 will ensure constant contact between surfaces 145 and 136 while driver 130 will adjust height of oral cavity through its own cranial movements that translate caudal mandibular advancement, facilitating mouth opening and thus increase oral cavity volume in order to create room for the advancing tongue while simultaneously stiffening the soft palate and Uvula (through the muscles palatoglossus, palatopharyngeus and tensor palatini). This entire process will work in synergy (keeping the person’s sleep undisturbed) to increase cross-sectional area of upper airway and increase the cubic volume of the oral cavity which in turn allows 150L / R (through the controller) in 116 to appropriately incrementally protrude the base of tongue forward into the increased oral cavity volume utilizing electric stimulation of the tongue nerves and muscles (details described elsewhere in this document), further increasing the cross-sectional area of the upper airway (the tongue forms the anterior wall of the upper airway).
[0114] In the natural state, the mandible must rotate beyond this initial 13 degrees, typically through another 7 to 13 degrees to have an effect on the airway size. This natural movementAttorney Docket 12572.012WO1comes at the price of reducing the antero-posterior (AP) diameter of the airway, thus constricting the airway. In an example, where the arcuately shaped side 145 is based on a 15 degrees jaw rotation (end to end) curvature, i.e., qi and q2are 15 degrees each or they may be any combination of two different angles that add up to 30 degrees. The approximate midpoint 147 of the arc 145 is the point at which transition between angle of q2and qi occurs and is approximately the point at which the mandible (mouth) is expected to have opened or rotated to the first 13 degrees (12 tol5 degree range). Total theta at the point of transition 147 = 180 - (qi + q2).Surface 136 of driver 132 should align with the lower part of surface 145 closer to 143 when the mouth is completely closed (Centric Occlusion CO with a Centric Relation CR between mandibular and maxillary incisor teeth). Angle of q2 can be different from angle of qi, i.e. the arc may or may not be one fixed radius from TMJ. Each of the qi and q2 should remain between the ranges of 12-15 degrees each although both qi or q2 or both could be zero degrees each (0-15 degrees each). These angles could exceed 15 degrees each based on individual needs of the user / patient. Total of (qi + q2) will ordinarily be between 24-30 degrees but could be 0-30 degrees or greater. Theta at point of transition 147 is (180 - (qi+ q2)) = 150 to 180 degrees unless angles of qi and or q2 exceeded 15 degrees. A q of 0 degrees will essentially create a straight vertical posterior surface 145 and would require a similar angle for surface 136. An angle of 180 would produce incremental forward protrusive movement of the mandible throughout the entire range of mandibular rotation (CR / CO to MMO) during mouth opening. The congruent relationship of surfaces 145 and 136 may create a posterior lean in the vertical axes of both surfaces such that their superior (cranial) edges may be posterior in relationship to their inferior (caudal) edges, thereby facilitating an anterior mandibular advancement as surface 145 slides down surface 136 with mouth opening (caudal mandibular advancement).
[0115] q2is primarily useful to control neutral mandibular protrusion during the initial 13 degrees of mandibular rotation (although protrusive flange can protrude the mandible when using MRD with motorized protrusive flange option) but can be adjusted to produce protrusive movement (the more q2 is, the less the radius of mandibular incisor to TMJ, the less protrusion of the mandible during early rotation or mouth opening and the less q2 is the more protrusion with each degree of mandibular rotation). On the other hand, qi is used to create the majority of the forward mandibular protrusion during the remainder of the mandibular rotation or mouth opening all the way to MMO (Maximum mouth opening). Resistance to mouth opening will also occur during this part of mandibular rotation due to the resistance from stretching the muscles of the TMJ as the mandible incrementally protrudes with every additional degree of mandibular rotation. Increasing qi will cause even more protrusion of mandible and thus also cause incremental resistance to mouth opening created by forward jaw movement. Essentially, if theAttorney Docket 12572.012WO1desired outcome is to keep the mouth closed or barely open (CR / CO position), one could use only qi and remove q2 altogether. This would require an arcuate or non-arcuate straight posterior surface 145 with qi of 0-15 degrees from the vertical axis starting at base 143 all the way up to 142 as shown in FIG. 6 and FIG. 7 with a corresponding surface 136 that is straight non-arcuate surface with a corresponding angle 90 + qi or a corresponding arcuate surface that leans back as shown in FIG. 6 or combination of arcuate and non-arcuate surfaces such as shown in FIG. 6. Under these circumstances, greater the qi greater the protrusion of the mandible with the least amount of mandibular rotation or mouth opening (mm of protrusion for each degree of mandibular rotation) and thus also ensure the highest resistance to mandibular rotation and mouth opening to match the needs of the user / patient. In an example, where the arcuately shaped side 145 is customized with qi and q2of 15 degrees each as well (total theta = 180-30 = 150) for the sake of simplicity of driving home the point, a mandibular rotation or mouth opening of about 20 degrees will protrude the jaw anteriorly about 5 mm and a mandibular rotation of about 24 degrees will protrude the jaw anteriorly about 11 mm. Since the MPD (Maximum Protrusive Distance with range of 6-10 mm) typically has an absolute maximum of 10 mm, 11 mm is nearly impossible for most people and thus the mechanics of the device create the environment where the mouth will not open to MMO (Maximum mouth opening) of 24 degrees. However, as in some individuals, maximum advancement may be up to 15 mm, in those individuals the device would allow the freedom of further advancement.
[0116] The releasably attachable features of the flange 114' accommodates the interchangeability of protrusive flanges 114 of different shapes and sizes to provide the best fit for the user’s mouth.
[0117] Turning now to FIGS. 11 to 14, some people in need of Continuous Open Airway Technology (COAT) may suffer from dysfunction or abnormalities of the temporo-mandibular joint (TMJ). These individuals may not have evidence of TMJ disease but may have mild restriction of the range of movement of the TMJ and mandibular advancement. As such, milder advancements of the mandible are needed for these individuals when using a mandibular repositioning device (MRD), such as the MRD 800 of FIG. 11. The MRD 800 has Dynamic Continuous Open Airway Technology (DCOAT) because the mandible will follow Arc2 of FIG.13 in which as the mandible drops to open the mouth, the mandible will move forward in small increments because of the shape of the protrusive flange 814 and the driver flange 832, thereby opening the airway. This is described in detail in U.S. Application No. 17 / 098,355. In comparison, Arm demonstrates the movement of commercially available COAT MRDs, which allow the mandible to open caudally, but allow the mandible to fall backward toward the throat; thus, obstructing the airway or adding to the obstruction.Attorney Docket 12572.012WO1
[0118] Turning now to FIGS. 11, 12 and 17, the various MRDs 800 have a concave-to-convex curvature moving from the base 816 to the most cranial point 818 of the posterior side 815 (or trailing edge) of the protrusive flange 814 of the mandibular piece 804 and a convex curvature 835 of the anterior side 833 (leading edge) of the driver flange 832. While FIG. 11 only shows the left side of the MRD 800, it is understood that the right side can be the same, and FIG. 12 shows a left side and has a mirror image for the right side. It is also understood that each side (left and right) of the mandibular piece and or the maxillary piece may, in fact, be just partial (2-5 teeth) coverings that may end with the anterior or leading edges 817 and 833 of the mandibular and maxillary pieces respectively or may extend further anteriorly to cover more teeth. The number of teeth covered may be different for the right and left side of each of these pieces as well. Thus, there may be up to 4 individual pieces, Two (mandibular and maxillary) for the right and two for the left. This will provide therapeutics for individuals who have a mouth that is too small (micrognathia) to fit an entire bulky device. For most user’s the left side and the right side will be mirror images, but if the user has a difference in jaw and / or facial structure making one side different from the other, the device can be custom shaped to accommodate the differences. The protrusive flange 814 extends cranially from the mandibular piece 804 which has a teeth covering 806 for the lower teeth. The driver flange 832 protrudes laterally outward from the side of the maxillary piece 802 a distance sufficient to engage the posterior side 815 of the protrusive flange 814 with the anterior side 833 thereof The driver flange 832 has a base 834 positioned on the maxillary piece 802, i.e., the base of the driver flange does not extend caudally in an overlapping manner with the mandibular piece 804 in this embodiment. However, in another embodiment it may extend caudally as an extension of 835 in a way that it will be alongside (buccal side) of the mandibular piece 804, thus providing additional caudal anterior surface 833 for maintaining articulation with the posterior (trailing) surface 815 of the protrusive flange 814 during extremes of mouth opening such as yawning or otherwise. The maxillary piece 802 has a teeth covering 807 for the upper teeth. The protrusive flange 814 and the driver flange 832 are not shown in these embodiments to have the housings with the motor and mechanism for moving the flanges to provide the movements described herein for the other embodiment, but they are equally usable with such mechanisms and all the systems described herein.
[0119] The concave-to-convex curvature of the posterior side 815 of the protrusive flange 814 has a concave portion 850 most proximate the base of the protrusive flange. Cranially above the concave portion 850 is the convex section 852. The shape and positions of the concave and convex portions 850, 852 is described in more detail with reference to FIG. 14. The mathematical model in FIG. 14, was created using a scale of 1 cm = 10 mm. Here, the dental horizontal axis (AH) is represented by segment BC and runs horizontally between the mandibularAttorney Docket 12572.012WO1teeth (crowns of the teeth) along the plane and the maxillary teeth (crowns) above the plane. Thus, the mandibular covering’s part of the MRD lies below the horizontal axis while the maxillary covering’s part lies above the horizontal axis. A vertical axis (Av) is drawn perpendicular to the dental horizontal axis at a position passing between the protrusive flange 814 and the driver flange 832 in the at rest position shown in FIG. 13. The rest position is a position of the mandible at which there is no stress on the TMJ. This axis passes between the mating point V2 of the protrusive flange 814 and the point P2 of the driver flange 832. Point A represents the TMJ at rest and an axis parallel to the vertical axis (Av) is drawn through point A, called the TMJ axis (ATMJ). Point B is the point where the horizontal axis and the angle of the mandible intersect. The angle ABC created thus represents an angle adjacent to the angle of the ramus of the mandible. It is typically 40 degrees since the angle of the ramus of the mandible is 140 degrees on average. However, significant age, race and gender variations exist. We have assumed an angle of the ramus to be 100 degrees and the adjacent angle to be 80 degrees for sake of simplicity. The more obtuse the angle of the ramus, the more obtuse the tangent T and the greater the lean in the surface 835 of the protrusive flange 814 and surface 833 of the driver flange 832. Point C is the point where the TMJH vertical axis and the horizontal axis intersect. Point D is a mid-point of the length of the segment AC. Point E is a point along the TMJ axis that is at 2 / 3 of the height (HDF) of the driver flange 832. Point F is the mirror of point D along the TMJ axis and Point G is the mirror of point A along the TMJ axis, i.e., a negative value equal to point D and Point A, respectively, below the horizontal dental axis. Point El is the mirror of point E on a vertical axis parallel to the TMJ axis but positioned at the front of the incisors (Ai). Average dimensions were used in FIG. 14, and it is therefore understood that these dimensions may vary from individual to individual based on natural variations of body size, jaw size, head size and variations created by abnormalities of the human body as well.
[0120] The primary concept is to use a tangent (T) that is parallel to the lean of the Ramus of the mandible (represented by line segment AB) in relationship to the horizontal axis (AH) that passes between the protrusive flange 814 and the driver flange 832 in the at rest position shown in FIG. 14. This creates an angle within the range of 10° to 50° with the vertical axis (Av) on the maxillary side of the horizontal axis (AH), which we call qi. For the purpose of the following description and simplicity, 10° was selected for qi and qi = q2. However, qi can be any value within the 10° to 50° range. The tangent (T) defines the point V2 of the protrusive flange 814 and the point P2 of the driver flange 832 on the convex portions thereof, which are aligned in the at rest position. This is referred to as point V2P2 and is a point where three tangents meet to create the tangent (T). These are designed to meet at the same point although they do not always have to, especially, if a design for any individual requires a variance from this concept. Also, if theAttorney Docket 12572.012WO1Ramus angle is different in each subject from what we have used for this discussion, T may change.
[0121] The five points labeled in FIG. 14 for the protrusive flange 814 are identified in this paragraph. Point Vi is the lowest point on the trailing edge 815 of the protrusive flange 414 where it lands on the mandibular covering of the MRD. Point V2 is where the tangent (T) coincides with point P2. Point V3 is the most cranial point of the trailing edge 815 of the protrusive flange 814. Point V4 is the lowest point of the leading edge 817 of the protrusive flange 814. Point V5 is the high point where V3 reflects and meets the leading edge 817.
[0122] The three points labeled in FIG. 14 for the driver flange 832 are identified in this paragraph. Point Pi is the lowest point of the leading edge 833 of the drive flange 832. P2 is the point where tangent (T) coincides with point V2. Point P3 is the most cranial point of the leading edge 833.
[0123] At T = 10°, the very front of the incisor part of the MRD to point C (the perpendicular dropped from A) appears to be 84 mm long. The midpoint of this segment is 42 mm (referred to herein as the midpoint length) from either end is at point V2. This is an average distance and may vary on a case-by-case basis (as will all other measurements). About 4.6 mm above point C is a point that is one third of the height of segment AC measured from the horizontal dental plane, designated as point H. Using point H as a center point, a first arc Vi - V2P2 defining the curvature of the concave portion 850 of the trailing edge of protrusive flange 814 is drawn and a second arc Pi - P2- P3 (the entire leading edge of protrusive drive 832 is drawn using a radius 1 (01) of 42 mm (equal to the midpoint length). The 42 mm length for the radius could vary on a case-by-case basis.
[0124] The second arc Pi - P2- P3 defines almost the entire leading edge of the driver flange 832. The radius that will be used to draw the leading edge of the driver flange is about 0.2-0.5 mm shorter than the radius used to draw the trailing edge 815 of the protrusive flange 814 to allow a small play for the purpose of proper articulation. The leading edge 833 of the driver flange 832 has a back-cut portion 854 most proximate the point Pi. Pi is described by a different radius, radius 4 (04) of 52 mm on average. The center point used to draw the arc for the back-cut portion 854 is point D such that segment EC = ED = 11 mm.
[0125] Point E is created by drawing a horizontal line from the point V2P2 such that the angle created by V2P2- C - Vi= 10° thus allowing the point V2P2 to be the point where the tangent T = 10° from the vertical axis. Now extending the horizontal line that passes through the points V2P2 and E further to the left allows creation of a point Ei, such that segment V2P2 - Ei = 42 mm = segment V2P2- E. Extending the line H similarly will allow the creation of Hi. With Ei as center point using the same radius 02 = 42 mm another arch is drawn that starts at V2P2 and extendsAttorney Docket 12572.012WO1upwards to V3, thus completing the remainder of the trailing edge of the protrusive flange 814. Hi may similarly be used and any point between Ei and Hi may also be used for the same purpose depending on the amount of convexity required at the top of the protrusive flange 814 to create best mandibular advancement for each individual person.
[0126] To build the leading edge 817 of the protrusive flange 814, Point F was used as the center to draw arc V4 - V5. This was then smoothed out at the top for a smooth transition to the trailing edge 815 and to avoid creating pointed edges. The convex curvature of the leading edge 817 is oriented with its curvature tilted toward the TMJ such that the most cranial point 818 (point V5) is more proximate point V2 than point V4. However, turning now to FIGS. 15 and 16, an alternate embodiment 800'for the MRD is shown in which the leading edge 817 of the protrusive flange 814 can be more linear, yet still oriented tilted with the most cranial point 818 pointed toward the TMJ. Additionally, FIG. 15 has a back-cut portion 864 to the convex portion 852 most proximate the most cranial point 818, back-cut toward the most cranial point 818. FIG.16 is a front view of the MRD 800 of FIG. 15 in a full -open mouth position with the back-cut portion 864 of the protrusive flange 814 seated against the back-cup portion 854 of the driver flange 832.
[0127] A user in need of an open airway, most often during sleep, but not limited thereto, inserts the maxillary and mandibular device of any of the embodiments disclosed herein into their mouth and goes about with their activity or goes to sleep. With respect to the shape of the flanges in FIGS. 11-22, when the user moves the mandible downward, such as normal relaxation during sleep, the protrusive flange 814 of the mandibular piece 804 moves along the convex curvature of the driver flange 832, which will move the mandible forward, see the increments of movement set forth in Table 1 above, and naturally opens the airway. Some users are capable of opening their mouths wider than others, and if, their mouth can open to a distance that is greater than the height of the protrusive flange 814 on the mandibular piece 804, there is a chance that the protrusive flange 814 could become disengaged from the driver flange 832 of the maxillary piece 802. To maintain contact between the mandibular piece 904 and maxillary piece 802 (prevent disengagement) during anterior-posterior repositioning and cranial -caudal repositioning, especially when both types of repositioning occur simultaneously, a plateau 870 of a preselected height (Hp) has been added to the mandibular repositioning devices of FIGS. 18-22 between the base 816 of the protrusive flange 814 and the floor 872 of the tooth covering 806 of the mandibular piece. The preselected height (Hp) of the plateau 870 prevents disconnect between each protrusive flange 814 and its respective driver flange 832 relative to a fully open mouth measurement between incisors of the user by having a height that compensates for the difference between the fully open mount measurement and the height of the protrusive flange (HPF).Attorney Docket 12572.012WO1
[0128] Referring to FIGS. 18-22, the preselected height (Hp) for these examples was selected to be 1.06 mm because the user was capable of opening their mount 20.06 mm and the flange height (HPF) was 19 mm. The flange height is typically less than 20 mm and is often in the range of 17 mm to 19 mm for the average adult. In another example, if a user has a fully open mouth measurement of 36 mm and the protrusive flange height is 19 mm, the preselected height for the plateau is 17 mm. As best seen in FIGS. 18 and 19, the plateau 870 extends across the full width of the tooth covering 806 and has a length (L) equivalent to the length of the base of the protrusive flange 814. Here, the plateau 870 has a uniform preselected height (Hp) along the length (L) thereof.
[0129] Turning now to FIG. 20, the plateau 870' is wedge-shaped, thereby having a first height (Hi) at an anterior base 817 of the protrusive flange 814 that is greater than a second height (H2) at the posterior base 816 of the protrusive flange. The plateau 870'causes the concave-convex curvature of the protrusive flange 814 to be inclined relative to the mandibular piece 804, thus the driver flange 832 is also inclined equivalently to the plateau 870' to maintain the engaged convex to convex mating curvature thereof. This creates a gap 872 between the driver flange 832 and the mandibular piece 804.
[0130] FIGS. 21 and 22 are examples of different embodiments for filling this gap with either an extension of the plateau 870'or of the driver flange 832, respectively. In FIG. 21, the plateau 870' has an extension 874 that extends posteriorly to a posterior terminus surface 876 of the tooth covering 806 of the mandibular piece 804. The extension 874 continues the wedge shape of the plateau 870' and terminates with a third height (H3) that is less than the first height (Hi) and the second height (H2). In FIG. 22, the plateau terminates posteriorly at the posterior base 816 of the protrusive flange 814 and the driver flange 832 has an extension 878 that extends caudally with its anterior side extending the convex curvature thereof past the posterior base 816 of the protrusive flange 814 into a gap 872 (FIG. 20). The driver flange 832 has a base that is seated on the mandibular piece 804 as a result of the presence of the extension 878. The extension 874 and 878 provide the benefit of added space for the housing in which the electrical components, motors, power sources, etc. that are described herein are enclosed. In another embodiment, extension 878 may extend caudally adjacent to the mandibular piece only thus allowing an extension for continued articulation between surfaces 833 and 815 with extremes of mouth opening.
[0131] Turning now to FIG. 23, the plateau provides significant benefits to the combined effect of the protrusive flange 814 and the driver flange 832 (anterior-posterior repositioning and cranial-caudal repositioning). For example, looking at columns 3 and 4 of FIG. 23, if a user actively opens their mouth 8.28 mm (5 degrees) in the absences of a plateau, the AVMLRD-Attorney Docket 12572.012WO1aided anterior movement of the mandible is 6.25 mm for the average adult. With any of the mandibular repositioning devices of FIG. 18-22, which have a protrusive flange height of 19 mm and a plateau of 1.06 mm, and an anterior movement selected to be 5mm at the rest position based on the curvature profdes of the protrusive flange and the driver flange, the same amount of anterior movement is achieved by opening the user’s mouth just 1 degree. The anterior movement for the at rest position is typically set to be in the range of 1 mm to 6 mm (see the header of FIG. 23 at the far left). Without the plateau, the mandibular repositioning device has a limited range for the cranial -caudal repositioning as determined by the height of the protrusive flange, in other words, the addition of a plateau extends this range.
[0132] Still referring to FIG. 23, it has been determined that a combined effect within the 1 mm to 6 mm anterior movement at the rest position of: (i) Area 0: 2.25 mm to 7.4 mm is useful for treating primary snoring disorder and mild OSA; (ii) Area 1 and Area 2: 7.5 mm to 10.9 mm is useful to treat mild, moderate, and severe OSA with lowest saturation range of 81% to 90%; (ii) Area 3: 11 mm to 13.9 mm is useful to treat moderate and severe OSA with lowest saturation range of 79% to 81%; (iv) Area 4: 14 mm to 17.9 mm is useful to treat severe OSA with lowest saturation range of 76% to 79%; and (v) Area 5: 18 mm to 28 mm is useful to treat severe OSA with lowest saturation ranges below 76%. Further, the most useful is Area 1 : a 5 mm to 6 mm anterior advancement in the rest position (central occlusion or centric relationship) with a 2 to 3 mm degree mouth opening by the user will treat mild to moderate OSA. Using the Area 1 configuration and the flange dimensions described for FIG. 18, the improvements expected for various parameters for a user were theoretically calculated and are listed in the table in FIG. 24.
[0133] Also, theoretical oxygen saturation improvements were calculated for the combined effect from 8.5 mm to 29 mm (from Area 1 to Area 5 of FIG. 23). A sleep study of a user was conducted for a user having a mouth opening calculation: 23 mm mouth opening or 14 degrees opening with 0 mm Anterior Advancement, 23 mm Vertical Advancement, 17.5 Total AVMLR Advancement. A 17.5 total AVMLR combined effect is predicted to provide a 13.8% increase in oxygen saturation based on Table 2 above. The sleep study data is presented in FIG. 25. The AVMLR provided the user a 13.6% increase in oxygen saturation, which is in direct correlation to the theoretical improvement. Moreover, the data from the sleep study with the AVMLRD is shown in FIG. 25 in contrast to data pre-treatment and for treatment with a BiPAP machine. The user wearing the AVMLR experienced overall better sleep than using the BiPAP machine, in particular, improvement in every category of the sleep study, including a 50% decrease in respiratory disturbance and a 66.6% increase in REM sleep as compared to the BiPAP effects. The AVMLRD outperformed the BiPAP treatment with superior effect, including a greater thanAttorney Docket 12572.012WO110% increase in 5 out of seven categories and a greater than 20% increase in four of the seven categories.
[0134] In any and all of the embodiments disclosed herein, the protrusive flange 814 may be molded as an integral portion of the mandibular piece 804 but is preferably a removably attachable flange. When the flange is removable, it may include a hole or depression 860 as shown in FIG. 11 to receive a tool to activate a release of the fastener holding the removable attachable flange in place on the mandibular piece 804. Likewise, the drive flange 832 may be molded as an integral portion of the maxillary piece 802 or it may be removable attachable thereto. The fasteners for holding the flanges to their respective pieces 802, 804 can be any specifically described herein, and commercially available, or any hereinafter developed.
[0135] One of the benefits of the removability of the protrusive flange and / or the driver flange is the ability to offer a kit having one or both of the maxillary piece and the mandibular piece having a removable flange and a plurality of said flanges to accomplish different amounts of anterior-posterior repositioning and cranial-caudal repositioning. In one embodiment, the kit has both a maxillary piece and a mandibular piece that have removably replaceable flanges, driver and protrusive flanges, respectively and a plurality of each flange in sets of protrusive and driver flanges to achieve different amounts of anterior-posterior repositioning and cranial-caudal repositioning.
[0136] In one embodiment, a plurality of left and right protrusive flange pairs are provided with the kit and at least one of the plurality of left and right protrusive flange pairs has a plateau of a preselected height between a base of each protrusive flange and a keyed slider extending caudally from the protrusive flange. The preselected height of the plateau prevents disconnect between each protrusive flange and its respective driver flange relative to a fully open mouth measurement between incisors of the user. Each protrusive flange engagingly saddles either a left backmost teeth mold or a right backmost teeth mold of the mandibular piece as part of its respective keyways described above against cranial movement. The plurality of left and right protrusive flange pairs differ in protrusive flange height (HPF) , angle, posterior side distance from the posterior terminus surface 876, and combinations thereof to provide differing effects to the user.
[0137] Differing posterior lean is possible for the driver flange(s). An embodiment with the most posterior lean, has a superior width, as measured from a side view of the driver flange, that is much smaller than the inferior width of the driver flange, thereby tilting the convex curvature of the anterior side posteriorly as you move from an inferior base to a superior cranial point thereof. In contrast, a driver flange that has the smallest (least) posterior lean, has the smallest numerical difference between the inferior width and the superior width. The convex curvatureAttorney Docket 12572.012WO1can be increased, decrease, or adjusted with a preselected amount of posterior lean. Such changes to the convex curvature are selected to enable the mandible of the user to advance incrementally more with mouth opening. Less superior lean advances the mandible in the anterior direction less with each degree of mouth opening. In contrast, more superior lean advances the mandible in the anterior direction more with each degree of mouth opening. For example, in one embodiment, the posterior lean may provide only a 1 mm anterior advancement with each degree of mouth opening, and in another embodiment, the posterior lean may provide a 3 mm anterior advancement with each degree of mouth opening. The flange on the mandibular piece will also lean more or lean less to provide the best range of anterior and vertical mandibular advancement.
[0138] In one embodiment, one pair of the plurality of left and right protrusive flanges provides the user with a 6 mm anterior advancement of the mandible. This embodiment can also have a pair of the plurality of left and right driver flanges that provides the user with a 6 mm anterior advancement of the mandible, thereby providing a 12 mm net anterior advancement for the mandible in the rest position. As noted above, the pairs of flanges are typically mirror images of one another unless the user has a jaw or face asymmetry.
[0139] Turning now to FIG. 26, an alternate embodiment to those in FIGS. 1-4 is shown that has both the anterior-posterior movement and the cranial-caudal movement of the mandibular repositioning device integrated into the maxillary piece 802 for control of the driver flange 832. The maxillary piece 804, on its buccal aspect, has a housing 1008 at each of the left and right molar portion, which each enclose, in a fluid-tight manner, a power source 1020 electrically connected to a piezo motor 1022 and to an encoder 1023 that controls the movement of a rod 1025 operatively connected to the piezo motor 1022 and to the driver flange 832. The power source 1020 is also electrically connected to a circuit board (microprocessor) 1024 that is in operative communication with the encoder and any of the sensor, stimulators, drug dispensers, etc. disclosed herein that are included in the maxillary piece. The rod 1025 encloses a set of robotic arms that move synchronously or opposite to each other (gliding together or sliding away from each other) driven mechanically, electrically, or electromagnetically by the piezo motor or electric and magnetic fields (EMF) generating coil that provides magnetic forces or mechanical forces to glide or slide the rod / arms. These are electric and magnetic fields (EMF) generated within using an EMF powered synchromesh and induction motor. Synchronous motors have an advantage of constant speed, steady load and operate with low voltage current or micro-voltage current. Absence of gearing gives them a smooth and quiet functionality that will be beneficial for this application. Induction motors have sustained torque and variable speed. Synchronous motors have pull up torque. Combination of these two facilitates movements starting after longAttorney Docket 12572.012WO1periods of quiescence, continuous push-pull movements, and reversal of motor rotation. This creates the ideal combination that provides anterior and posterior, push-pull movements of the driver flange 832.
[0140] A first arm drives the driver flange 832 anteriorly and posteriorly. A second arm drives the lean of the anterior surface of the driver flange. The distal end 1027 of the rod 1025 houses the two arm terminations into ball-socket terminals or other hinged terminals in the housing within driver flange 832. When both, maxillary and mandibular pieces are in place and a bite or clench is carried out or the flanges come in contact with each other or any form of trigger that will provide sensory activation of the device, such as activation through a handheld device, controller station or simply inserting all the relevant pieces into the mouth. Then the piezo motor activates (this provides the system with a signal that the device is installed in the oral cavity for use) and all components including the AVMLRD, handheld device, controller station, cloudbased repository of memory are activated. The system goes through a formal boot process and checks all components are functioning normally and live to go. The user gets a communication and then confirms active status of the system and finalizes activation. In the event that the user is incapacitated, next-of-kin followed by physician or EMS are notified in real time. It then moves the driver flange anteriorly using the first arm to bring the protrusive flange 814 to the prescribed position such as a Centric Occlusion or 1 mm to 6 mm advancement. In doing so, it clears room between the housing 1008 and the driver flange 832 that allows the second arm to perform prescribed posterior lean of driver flange 832. Both, the first arm and the second arm are actively moving back and forth (+ and - movements in their respective axes) during active operation and all movements are actively powered. The lean function allows the anterior leading edge of the driver flange 832 to maintain the prescribed lean and adjust the lean dynamically during use on an as needed basis.
[0141] The piezo motor 1022 in each housing 1008 is configured for three specific functions of the rod and the two arms within the rod. Cranial to caudal adjustments of the rod 1025 (i.e., first and second arms) through rotation around a central axis, anterior-posterior gliding of the rod (performed by first arm) and preferential sliding of the second arm perform the lean function. Alternately, the cranial to caudal adjustments is performed through movement of the entire piezo motor within the housing 1022 using a robotic armature, which is accomplished by the wheels 1029 positioned above the rod 1025. Caudal movement of the driver flange 832 enables the drive flange 832 to accompany the caudal movement of the protrusive flange 814 as the user opens their mouth and the reverse when closing their mouth. Alternately, driver flange 832 actively pushes the mandibular piece 804 caudally as the first arm anteriorly advances and the second arm leans posteriorly creating a positive pressure at the caudal anterior leading edge ofAttorney Docket 12572.012WO1the driver flange 832, nudging the trailing edge of the protrusive flange 814 and its caudal root to move caudally; thus, actively opening the user’s mouth. This keeps the two flanges 814, 832 in constant contact with one another, thereby reducing the likelihood or possibility of a disconnect therebetween. The anterior-posterior movement and cranial-caudal movement directed by the piezo motor can occur simultaneously, individually, and / or sequentially.
[0142] The circuit board 1024 has a microprocessor comprising a quantum microchiplet and / or a photonic integrated circuit and nontransitory memory. While FIG. 26 shows the left housing 1008 with circuity board 1024, the right housing will likewise include the circuit board and other components. The left and right circuit boards may have symmetric functions or shared functionality, communicating with each other continuously, and external controller, and / or other smart devices or through a two-way transmitter housed inside the protrusive flange 814. The microprocessor has stored in the nontransitory memory a first algorithm controlling the cranial-caudal movement of the piezo-electric motor relative to data receivable from one or more sensors. The sensors are typically in the oral cavity but are not limited thereto. The sensors can measure airway cross-sectional area, airflow volume, airflow velocity and pressure, airflow resistance, systolic and diastolic blood pressure, electrical activity of the heart, oxygen level, heart rate, and combinations thereof. The systolic and diastolic blood pressure and electrical activity of the heart may be measured by capacitive micro-machined ultrasound. Position sensors can be included that measure a first distance for cranial -caudal movement and a second distance for anterior-posterior movement of the driver flange.
[0143] The microprocessor has stored therein a second algorithm for anterior-posterior movement and lean functionality as described above. In one embodiment, the anterior-posterior movement is corelated to movement desirable when the user is under the influence such as effect of medication, sedation, anesthesia, or alcohol.
[0144] The microprocessor has artificial intelligence to learn from the collected data form the sensors when to make anterior-posterior and / or cranial -caudal adjustments to the driver flange and can do so before a measured parameter drops or moves out of a set range of values so as to maintain those values as close to the mean as possible and within a certain set of 1 to 6 standard deviations from the mean. In one embodiment, increasing airflow resistance, decreasing airflow volume, and decreasing cross-sectional area of the airway (SMCA) will immediately trigger the prescribed caudal and anterior movements through the first arm and required lean through the second arm thus moving the mandible and the tongue anteriorly and caudally at an incremental level desired with continuous feedback through the sensors. As airflow resistance drops, airflow volume increases and SMCA begins to increase, reverse movements of the first and second armsAttorney Docket 12572.012WO1would result in raising the mandible cranially and simultaneously or sequentially retracting the mandible posteriorly.
[0145] Turning now to FIG. 27, another embodiment having anterior-posterior movement and the cranial -caudal movement of the mandibular repositioning device integrated into the maxillary piece 802 for control of the driver flange 832 is shown. The driver flange 832 has a posteriorly extending extension 1032 extending from the most caudal portion of the driver flange 832. The extension 1032 includes a first plate 1040 therein connected to a first robotic arm 1042 and a first position sensor 1044. The main portion 1034 of the driver flange 832 includes a second plate 1050 connected to a second robotic arm 1052 and a second position sensor 1054. The first plate 1040 is juxtaposed to the second plate 1050 at the junction of the extension 1033 to the main portion 1034 of the driver flange 832. The first plate and the second plate 1040, 1050 can be fixedly connected to move the entire flange together, such that the movement is more angular, thereby having both anterior-posterior and cranial-caudal adjustments simultaneously. In another embodiment, the extension 1033 may move independently from the main portion 1034 as represented by the dashed line in FIG. 27. The robotic arms, 1042, 1052 may be extending arms, such as telescoping arms, and terminate at their respective plates 1040, 1050 with an articulating joint, such as a ball and socket joint, for greater range of motion.
[0146] The embodiments of FIGS. 27-28 have other features similar to the embodiment of FIG. 26, such as the microprocessor 1024 and memory 1026 for artificial intelligence control of the robotic arms 1042, 1052 relative to data from sensors, including the first and second position sensors 1044, 1054, even if not illustrated in the figures.
[0147] Turning now to FIG. 28, the first plate 1040 is separate from the driver flange 832 and is seated in the bottom of the housing 1008. The first plate 1040 has its own motor 1022 that is separate and independent form a second motor 1022' that controls the movement of the second plate 1052 which is positioned inside the driver flange 832. As indicated for the other embodiments, the arms connecting each motor to each plate may be extending, e.g., telescoping, and have an articulated connection to its plate, e.g., a ball and socket joint. Here, there is a third motor 1022” ' present that is positioned with a third robotic arm 1062 to move the entire anterior-posterior assembly (second motor 1022', second robotic arm 1052, and second plate 1050) in the cranial -caudal direction, thereby moving the driver flange for cranial -caudal adjustments simultaneously, independently, and / or sequentially with anterior-posterior adjustments. As noted above, these adjustments may be used to maintain contact between the driver flange 832 and the protrusive flange 824 during caudal and anterior movement of the mandibular piece, thereby avoiding the cranial tip of the protrusive flange from dropping below the driver flange. This enables unrestricted mouth opening by the user.Attorney Docket 12572.012WO1
[0148] In one embodiment of FIG. 28, dual robotic arms 1042 connect the first plate 1040 to the first motor 1022 and dual robotic arms 1052 connect the second plate 1050 to the second motor 1022'. The presence of dual robotic arms 1042, 1052 provides the ability to introduce a tilt to the driver flange 832 and / or the first plate 1040. For the driver flange 832, the tilt function can have the more caudally positioned arm move more than the more cranially positioned arm such that the effect of a greater posterior lean is achieved, thereby providing more anterior advancement for each degree of mouth opening. Similarly, if desired, the opposite movement of the dual arms 1052 is possible to produces less posterior lean, thereby providing less anterior advancement for each degree of mouth opening.
[0149] Also, in the embodiment of FIG. 28, the dual robotic arms 1042 can move the posterior end of the first plate 1040 less than the anterior end of the first plate 1040. In one non-limiting example, for a mouth opening of 1 degree (1.66 mm) requires the posterior arm 1042pto move the posterior end of the first plate 0.95 mm and the anterior arm 1042ato move the anterior end of the first plate 1.06 mm. This can be used to introduce the equivalent of the plateau similar to those of FIG. 20-22 in the at rest position with dynamic alterations possible during activity or sleep through robotic and machine learning algorithms.
[0150] Each of the systems disclosed in FIGS. 26-29 has a power source 1020 that is rechargeable and has the recharging features described herein for other embodiments. Moreover, each system is compatible with the controller stations described herein and used artificial intelligence to drive the motor(s) 1022 and adjustments to the mandibular repositioning devices. The power source in all embodiments may be a rechargeable battery. In one embodiment, the rechargeable battery is one or more micro-lithium ion batteries. Solar / light charging energy source that can be recharged by ambient lighting (used in the watch maker industry) or solar power, may also be considered for a rechargeable source of energy. The rechargeable battery may have a maximum discharge milli -amperage creating a mechanical mandibular protrusion or retrusion ranging between 1-10 mm in linear dimensions for the movement of the drivers and or the operation of stimulators and / or sensors.
[0151] Turning now to FIG. 29, this embodiment has arms 2042, 2052 controlling movement of the protrusive flange 814 shown as the left molar region of the mandibular piece 804. The same is true for a right molar region. Each molar region has a housing 2008 of sufficient size to enclose electronics that accomplish anterior to posterior movement, cranial to caudal movement, and angular movement (0s). For the anterior to posterior movement, the housing has a waterproof groove 2010 through which the arms 2042, 2052 extends. The length (L) of the groove is in a range of 1 mm to 12 mm, preferably 5 mm to 12 mm to provide a range of anterior to posterior advancement. A first end 2043, 2053 of each arm 2042, 2052 is connected to aAttorney Docket 12572.012WO1respective receiver 2044, 2054 in the protrusive flange 814 at a position inside the base thereof or in a plateau 2070, if present, such as shown in FIG. 29. The receivers 2044, 2054 can provide a removably, replaceable snap-fit connection for changing the protrusive flange 814 or can receive a screw or other fastener. In one embodiment, the receivers 2044, 2054 facilitate a permanent attachment of the protrusive flange 814 to the arms 2042, 2052. When the plateau 2070 is present, it can have any of the features of the embodiments described herein.
[0152] The arms 2042, 2052 may be mechanically functional or may be robotic with artificial intelligence control thereof. The arms 2042, 2052 are juxtaposed to one another in an anterior to posterior relationship within the housing 2008. A second end 2045, 2055 of each robotic arm 2042, 2052 is operatively connected to a respective gear system 2048, 2058 that are individually controlled by a microprocessor 2024 within the housing 2008. The microprocessor 2024, a first motor 2022 and second motor 2022', power source 2020, at least one sensor 2025, and other optional electronics within the housing. The optional electronics can be any of the options discussed herein for any of the other embodiments. The individual control of the gear systems 2048, 2058 enables control of the arms 2042, 2052 simultaneously in synchronized or sequential operations or individually for any of the desired advancements for a particular patient’s needs. The arms 2042, 2052 in any embodiment can have a removably, replaceable snap-fit to their respective gear system 2048, 2058. As such, arms of differing lengths can be provided and used as suitable for different conditions of the user, such as a change in physical activity or a change in health.
[0153] Still referring to FIG. 29, the mandibular repositioning device can include any number and type of sensors 2025 and stimulators from any of the embodiments disclosed herein and the microprocessor 2024 can execute necessary algorithms to achieve the anterior to posterior movement, cranial to caudal movement, and angular movement. The arms 2042, 2052 can provide up to 12 mm of anterior to posterior movement, up to 14 mm of cranial to caudal movement, and up to 25 degrees of angular movement (0s) to the protrusive flange. To achieve the angular movement, the anteriorly positioned arm 2052 moves the protrusive flange more in the cranial direction than the posteriorly positioned arm 2042 as shown in FIG. 29. As discussed repeatedly herein, the anterior to posterior movement provides anterior mandibular and lingual advancement and the vertical and angular advancements provide caudal displacement of the mandible and tongue as well. In one embodiment, the microprocessor is a quantum microchip or a photonic integrated circuit, has non-transitory member, a renewable or rechargeable power source, a means to charge the power source, means for the microprocessors in each housing (right and left sides) to communicate with one another and / or external devices including those disclosed herein. Continuous machine learning will provide internal biofeedback and commandsAttorney Docket 12572.012WO1integrated with external resources. These embodiments for the protrusive flange are compatible with all other embodiments disclosed herein.
[0154] Referring back to FIGS. 1 and 4, at least one stimulator 116, but preferably both stimulators 116, include a first sensor 150L / R and / or a second sensor 152L / R, but preferably both sensors. 150L and 152L stands for the left side of the user and 150R and 152 R stands for the right side of the user. The sensors 150L / R and 152L / R may be selected from a variety of sensors to create which every combination is the most likely to be useful in diagnosing or treating the user. The sensors are selected form the group consisting of a pulse oximetry sensor, a vibration sensor, an airflow sensor, a pH sensor, a combination pulse oximetry / vibration and airflow sensor, an EKG sensor, EEG sensor, EMG sensor, EOG sensor, lactic acid sensor, a pulse transit time (PTT) sensor, an ultrasound sensor (echocardiography), an electro-oculogram sensor, a temperature sensor, a body position or jaw position sensor (such as a potentiometer), an electromyogram sensor, a pressure measurement sensor, a hygrometer sensor, a microphone or sound recording sensor, video recording, and hygroscopic / hydration sensor. In one embodiment the first sensor is a combination pulse oximetry / vibration and airflow sensor and the second sensor is a pH sensor. In another embodiment, the first sensor is a pulse oximetry sensor, and the second sensor is a vibration and airflow sensor. Any number of combinations of the sensors listed above is possible and can best be selected by a medical professional based on data relative to the pre-selected end user. Sensors in the left side and right side could be symmetric or complimentary or asymmetric. For example, CMUT / IVUS sensor may have better signal delivery and reception of carotid blood flow when placed on the left side and not as good a reading from the right side. Thus, it is placed only on the left side. The EKG sensor may have better reading from the right side than from the left side and thus is placed on the right side. Together, the EKG sensor and ultrasound sensor create complete cardiovascular hemodynamic data.
[0155] The pulse oximetry sensor 150 can be positioned at a position enabling direct contact with the base of the tongue from which data will be collected. This position can be generally antero-superiorly positioned for measuring pulse-oximetry through the blood-flow of the tongue. The vibration and airflow sensor 152 can be positioned at a position suitable for airflow measurements, which can indicate when there is a restriction of airflow, and vibration measurements (sub-sonic and sonic) that are an indication of inaudible and audible snores and speech detection or cough as well. The vibration and airflow sensor 152 can face posteriorly to measure snores and airflow resistance / pressure from the airway.
[0156] The stimulator 116 may also be accompanied by a sensor or sensors that can record EEG (electro-encephalogram), EOG (electro-oculogram), electromyogram (EMG) for the tongueAttorney Docket 12572.012WO1muscles and NC (Nerve conduction) data from the nerves of the tongue, pharynx and muscles of mastication (jaw muscles) and phonation (speech). These sensors may transmit these data to the controller 200 (described in more detail below) through variety of industry standard wireless protocols that are currently in use for wireless EMG, NC and EEG recordings in other skin surface applications in neurology and sleep laboratories. Data from such sensors will be useful for detection of various medical diseases as it will be computed in time-synchronized manner by the controller 200 and cloud based servers in system 300 described in more detail below and will help to determine cause-effect of many medical diseases. The sensors will also provide feedback to controller 200 to gauge effectiveness of electric stimulation of the tongue or forward movement of the tongue and mandible and thus allowing the controller to make fine adjustments to all components of the system.
[0157] The length L of each stimulator 116 will be pre-selected to fit the user’s mouth and tongue, in particular for adequate contact with the base of the tongue (genioglossus muscle) during sleep or while awake performing certain activities. While awake, the stimulator(s) can be used for muscle training or speech training or facilitation of swallowing mechanisms or for athletic performance enhancement. Each stimulator 116 has a single or dual electrode 154 or multiple electrodes or a large band of electrodes connected to the power source 120 and generates an electrical impulse that travels through the electrode to one or more of the lingual muscles of the tongue identified above, which contracts the lingual muscle(s) to create a forward movement of the tongue. The forward movement of the tongue increases the cross-sectional open airway diameter in transvers, vertical and antero-posterior dimensions, thus increasing the aggregate volume of open airway and exponentially reducing air-flow resistance. The power source for the single or dual electrode can be a direct current (DC) power source or may employ any other technology such as electro-magnetic energy, photon energy among other forms of energy. The electrical impulses’ power source will be in volts or microvolts and the current, likely in milli-Amps (usually 2-6 mA), will be pre-selected on a per patient basis. The power, current, and capacity will typically be within a range suitable for effective performance of mated hardware and safe for use with cardiac pacemakers, defibrillators, deep brain stimulators, or spinal cord stimulators.
[0158] The forward movement of the mandible (protrusion) is performed by lateral pterygoids, medial pterygoids and masseter muscles. These are stimulated by the mandibular branch of the trigeminal nerve. The neuronal firing rate drops during sleep relaxing these muscles causing the jaw to fall back (retrusion) and thus allowing the tongue to fall back (retro-glossal movement) into the airway as well creating a narrow airway which is the cause of obstructive sleep apnea, oxygen desaturation, elevated blood-pressure, cardiac arrhythmia, disruption inAttorney Docket 12572.012WO1sleep and nocturnal acid reflux. The transverse stimulator 116 can specifically target these muscle groups and their distributing nerve and stimulate and sense electrical activity of these various muscles individually or together inside the oral cavity.
[0159]
[0160] As seen in FIGS. 1 and 2, each housing 108, 109 of the mandibular and maxillary pieces, respectfully, include a charging member 118, 119, such as a charging plate, in an exterior surface thereof. In the figures, the charging plate is in a lateral side of the housing 108, 109, but is not limited thereto. As best seen in FIG. 3, the first driver 130 may be a flat plate connected to the motor 122 by the linkages 134. The motor 122, 123 in all embodiments may be a single or dual piezoelectric motor having a linearly movable linkage(s). Micro motors based on piezo electric materials are commercially available from Piezo Motor, a company headquartered in Sweden and may be modified as needed for use in the disclosed devices. The motor 122, 123 may include a position sensor.
[0161] As best seen in FIGS. 3 and 6, the maxillary piece 102 sits on the mandibular piece 104 with the first driver 130 operatively engaged with the maxillary piece 102 and the second driver 132 operatively engaged with the protrusive flange 114, 114', or 114' ' of the mandibular piece 104. Each of the drivers 130, 132 can move the jaws in increments of 0.1 mm up to 2 mm with each movement with a maximum of 12 mm in the respective direction. The protrusive flange 114 , 114', 114'', is moveable by the second driver 132 in a range from 0.1 mm to 11 mm and the first driver 130 can lift the maxillary portion in a range from 0.1 mm to 12 mm.
[0162] Referring again to FIG. 6, the second driver 132 has a head 136 that is shaped to fit the shape of the posterior side 145 of the protrusive flange 114'. The head 136 has a convexly-shaped anterior side to press against the posterior side 145 of the protrusive flange 114'.
[0163] Turning to FIG. 41, a model of a mandibular repositioning device configured to treat EIAH is presented with a plurality of labeled parameters. The parameters are determined by the Al-predicative algorithm described above. The MRD has the same or similar features as the MRD 100 and 800 including a plateau as described with respect to FIGS. 17-22. The plateau is present as part of the occlusal surface of the mandibular piece to define an opening distance in the rest position and to become part of the protrusive flange’s height. In the context of exercise-induced arterial hypoxemia mitigation, the mandibular protrusion vector produced by the geometry-defining parameters creates an antero-vertical mandibular displacement rather than the antero-superior displacement used in sleep-phase mandibular repositioning devices. The antero-vertical vector is biomechanically critical for exercise-phase EIAH mitigation because the user is upright, breathing at 40-70 cycles per minute, with active sternohyoid and geniohyoid muscle contraction. The geometry-defining parameters produced by the predictive algorithm for EIAHAttorney Docket 12572.012WO1mitigation comprise a posterior lean angle (a) of the cranially extending protrusive flange in a range of 4 degrees to 20 degrees from vertical, a plateau height (Hpiateau) in a range of 8 mm to 24 mm producing a vertical dimension of occlusion in a range of 12 mm to 24 mm, and a protrusive flange height (HPF) in a range of 24 mm to 36 mm above the mandibular plane cranial surface. These geometry-defining parameters are distinguished from sleep-phase device parameters, wherein the posterior lean angle is approximately 3 degrees from vertical and the vertical flange height is typically 17-19 mm.
[0164] As noted, the posterior lean angle (a) of the protrusive flange 114 is in a range of 4 degrees to 20 degrees from vertical. This angular range is biomechanically critical to exercisephase Total Antero-Vertical Mandibular-Lingual Repositioning (TAVMLR): a posterior lean angle of less than 4 degrees is insufficient to produce the antero-vertical advancement vector required for dynamic epiglottic clearance under high-ventilatory-load exercise conditions of 40-70 breaths per minute, while a posterior lean angle exceeding 20 degrees produces excessive anterior mandibular displacement that impairs exercise-phase occlusal stability and device retention under dynamic ventilatory loading. In contrast, a mandibular repositioning device configured for sleep-phase airway stabilization produces a displacement vector using a posterior lean angle of approximately 3 degrees from vertical.
[0165] Additionally, lingual flanges are present, for example lingual flanges 190L, 190R, but they extend inferiorly and lingually from a lingual surface of the teeth covering 106, 806 on each of a left side and a right side thereof, i.e., the flanges are bilateral and they define a subglossal shelf having a shelf depth (DS) measured inferiorly from the lingual gingival margin in a range of 12 mm to 24 mm on each side. The subglossal surface of each lingual flange 190 defines a lingual surface oriented at a lingual angle (0L) measured from the lingual gingival plane in a range of 15 degrees to 60 degrees. The lingual angle (0L) is selected to engage the lateral tongue base and floor-of-mouth musculature to effect dynamic stabilization of the hyoid bone under high-ventilatory-load exercise conditions. A shelf depth below 12 mm is insufficient to engage the floor-of-mouth musculature at the tongue base during exercise-phase mandibular depression, and a shelf depth exceeding 24 mm impairs exercise-phase comfort and occlusal loading distribution. A lingual angle below 15 degrees provides insufficient lingual repositioning force on the tongue base under high-airflow conditions, while a lingual angle exceeding 60 degrees produces excessive lingual displacement that impairs exercise-phase airway laminarization under dynamic ventilatory loading.
[0166] The protrusive flange height for ISA treatment as referenced with respect to FIGS. 1-29 have a flange height maximum of about 19 mm. In an embodiment configured for exercise-phase EIAH mitigation, the plateau has a height (Hpiateau) in a range of 8 mm to 24 mm and theAttorney Docket 12572.012WO1protrusive flange of the mandibular piece has a vertical height (HPF) measured from the cranial surface of the mandibular plane (MP) in a range of 24 mm to 36 mm. The combined effect of the plateau height and the protrusive flange height is a vertical dimension of occlusion (VDO) in a range of 12 mm to 24 mm. The plateau height of 8 mm to 24 mm is biomechanically critical for EIAH mitigation: a plateau height below 8 mm is insufficient to maintain mandibular engagement during exercise-phase mandibular depression associated with high-ventilatory-load breathing at 40-70 breaths per minute, while a plateau height exceeding 24 mm impairs exercisephase occlusal stability and increases cumulative loading on the temporomandibular joint during sustained athletic exertion. Additionally, different athletic pursuits requiring varying degrees of mandibular mobility may require individualized adjustment of the tooth covering thickness of the teeth covering 106, 806, 107, 807 to achieve an optimal VDO within the range of 12 mm to 24 mm for the individual user's EIAH condition and sport-specific requirements.
[0167] The protrusive flange height range is structurally distinct from the sleep-phase embodiment and is critical to maintaining the Dynamic Connected-Arc-of-Motion (DCOAT) engagement of the mandibular piece 804 with the maxillary piece 802 throughout the full range of exercise-phase mandibular displacement. A vertical flange height below 24 mm is insufficient to maintain driver flange engagement with the protrusive flange throughout the exercise-phase mandibular depression range during high-ventilatory-load breathing, resulting in disengagement of the antero-vertical mandibular repositioning vector at peak exertion. A vertical flange height exceeding 36 mm produces excessive cranial displacement of the hyoid bone (Airway Throttle Body) beyond the optimal antero-vertical vector range for EIAH mitigation and impairs exercisephase airway laminarization under dynamic ventilatory loading.
[0168] Turning now to FIG. 9, a mandibular device 101 is illustrated that has just the stimulator 116 and a mandibular teeth covering 105. As such, the maxillary piece can comprise of a teeth covering 107 as shown in FIG. 2 without the housings 109 or be absent, i.e., the user can just have the mandibular device 101 in their mouth during use. Dual housings 108' are present with one each proximate a left molar portion 110 and a right molar portion 112. A stimulator 116 extends from each housing 108' toward the tongue at a position to lie under the tongue in contact with lingual muscles, in particular the Genioglossus (GG), the Geniohyoid (GH), sub-mentalis (SM), and Glossopharyngeal (GP). Each housing 108' includes a charging feature 118 for recharging any battery(ies) housed therein, as described above. The stimulator / sensor protrusion 116 rather than being an integral part of the teeth covering can be removably attachable thereto, and optionally disposable or reusable.
[0169] Referring now to the cross-section of FIG. 10 through one of the stimulators 116, each stimulator 116 houses therein, in a fluid-tight manner, a first sensor 150, a second sensor 152,Attorney Docket 12572.012WO1and a stimulator electrode 154. In FIG. 10, the first sensor 150, the second sensor 152, and the stimulator electrode 154 are each electrically connected to the power source 120 within housing 108'. The electrical connections may be direct connections to the power source 120, which may be accomplished by a plug-n-play electrical connector 156, or, as represented by the dashed lines, may be accomplished by a plug-in style connector 157 to the microprocessor 159 and thereby to the power source.
[0170] In one embodiment, the first sensor 150 is a pulse oxygen sensor continually measuring oxygen data at the base of the tongue and the second sensor 152 is a vibration / air flow sensor measuring snoring, turbulent flow, and vibrations from inside the user’s mouth. As noted above with respect to FIG. 4, multiple other sensors and sensor combinations are possible that will provide data to the microprocessor 159. The circuit board 124 within the housing 108' is in operative connection to the power source to be powered and to control activation of the stimulator electrode 154 in response to data received by the circuit board 124, more particularly, the microprocessor 159, from the first sensor 150 and / or the second sensor 152. As discussed, the microprocessor 159 receives the sensor data, processes the sensor data, and determines whether the stimulator electrode 154 needs activated. Each of the stimulators 116 may include a pH electrode too. The pH electrode will measure the acidity at the back of the tongue, which if too high is an indication of chronic high acid reflux.
[0171] In one embodiment, only the first sensor 150 is present. The first sensor 150 may be, but is not limited to, a pulse oxygen sensor, a vibration and airflow sensor, a pH sensor, a doppler ultrasound, an M-Mode ultrasound, a 2D ultrasound, 3D ultrasound, a pressure plate for measuring bruxism, a pulse transit time sensor, non-invasive ventilation systolic / diastolic blood pressure sensor, a carotid doppler (trans-oral) sensor, or a cardiac trans-oral echocardiography sensor or a camera / videography system, or any other sensor identified herein. In one embodiment, the first sensor 150 is a pH sensor. With reference to FIG. 9, the first sensor 150 is a pulse oxygen sensor continually measuring oxygen data. The mandibular device 101 can be used with the controller station 200 in a diagnostic mode. When two housings 108' are present, each can have a protrusion 116 but can differ as to the type of sensor(s) present therein and one or both may include a stimulator. Since the mandibular device 101 can be used in a diagnostic mode or a treatment mode great versatility is provided by the systems herein. Furthermore, since the housings 108'can be removably attachable to the teeth covering 160, the housings 108'can be switched for housings having different sensors over a period of time to assess various parameters of the user, whether during the day, at night, or both. The mandibular or maxillary housings or teeth coverings, when used alone (mandibular or maxillary) should allow most speech functions and thus can be used during the course of a normal day.Attorney Docket 12572.012WO1
[0172] With reference back to FIG. 5, the data interfaces with standard Bluetooth functionality, WIFI functionality, and any other available or hereinafter developed wireless technology and the controller station 200 may be used as a mobile unit with such wireless capabilities, and as such may be carried to work or elsewhere. The controller station 200 will be interfaced with proprietary or open platform program that can be securely loaded on variety of electronic devices 310, such as computer systems and hand-held smart devices. The controller station 200 is illustrated for operatively controlling any of the mandibular lingual repositioning devices 100, 101 described above, which together define a system 300. The controller station 200 has a housing 201 defining a first charging unit 202 for receipt of the maxillary piece 102 and a second charging unit 204 for receipt of the mandibular piece 104. The first and second charging units 202, 204 may be receptacles defined in a surface of the housing 201. In another embodiment, the first and second charging units 202, 204 may be generally flat plates. The housing 201 has a display screen 203 for displaying information to a user and one or more ports 206 for connecting the charging station to power, other devices, and / or the internet. Alternately, instead of ports 206, the housing 201 can enclose wireless communication technology for other devices 310, for example, but not limited thereto, a printer, speakers, tablets, laptops, cellular phones, smart watches, and other cloud-based devices. The controller station 200 may include sensors to record ambient room conditions, such as light, temperature, humidity, noise / sound, etc. The controller station 200 optionally is battery powered and may include a rechargeable battery. The controller station 200 may be portable. Alternately, rather than having the first and second charging units 202, 204 integrated into the controlling station 200, a separate charging station (not shown) having a first and second charging unit is possible. The charging station may be portable.
[0173] When the charging station is separate from the controller station 200, the controller station may be incorporated into a hand-held smart device and such a smart device would share blue tooth, WIFI, Video, audio and communication capability with sensors. In one embodiment, the controller can be a proprietary software program for use with or an App (software application) having full functionality to function like the controller station 200. System 300 and controller station 200 in all its embodiments will be HIPPA and HITECH compliant for purpose of medical privacy. Interface with the wide variety of electronic health formats (EHR) would allow system 300 and controller station 200 and its operated systems to be available for real-time data download and upload, active health care worker involvement in user’s health care needs and would permit the health care worker to operate and alter any treatment and access and interpret diagnostic information provided by the system. As such controller station 200 and system 300 would allow newer formats of health care provisions such as tele-medicine and others yet to beAttorney Docket 12572.012WO1defined. System 300 may be integrated into a full-function health care software -hardware system for patient assessments (such as telemedicine), tests, treatments and medications.
[0174] The controller station 200 encloses a circuit board having a microprocessor, including memory (non-transitory computer readable media) in which is stored firmware and learning algorithms, having a receiver of electronic communications, and having a transmitter of electronic communications, including wireless communication capabilities to electronically communicate with at least the MLRD 100, 101 for real-time communications with the sensors on board the MLRD. The MLRD 100, 101 has microprocessors on-board with a transmitter to transmit raw data from all sensors, stimulators and pressure pellets exemplified by the pulse oximetry sensor, the vibration and airflow sensor, lingual stimulator, lateral pterygoid stimulator, medial pterygoid or masseter stimulator, EKG sensor, sub-lingual nitroglycerine pellet discharge, etc. to the controller station 200 in real-time aided by system 300 for processing into executional commands exemplified by movements of the first driver and / or the second driver and activation of the stimulator for tandem or synchronized movements and activation thereof, i.e., simultaneous, independent, or sequential activation of the motors and the stimulator, training of muscles of speech or swallowing including the sequence of movement and strength and duration of current or release of a medication for sublingual or aerosolized use. The controller station 200 can simultaneously transmits the instructions to the MLRD 100, 101 microprocessors in each housing 108, 109, 108' which implement the instructions, exemplified by synchronizing the cranial to caudal adjustments, the anterior to posterior adjustments, and activation of the stimulator etc. The MLRD may also operate as a stand-alone mandibular protrusive and vertical advancement device or as a stand-alone lingual / pterygoid stimulator device or a timed-medication release device as preferred by treating health care provider.
[0175] The circuit board of the controller station 200, in one example, receives data from the MLRD that includes but is not limited to the pulse oximetry sensor and / or the vibration and air sensor and activates the motors and the stimulator as needed after a pre-selected number of breaths of the user. The firmware and algorithms, including learning algorithms as well as standard algorithms, stored in the memory of the circuit board may define the pre-selected number of breaths to be every breath, every other breath, every five breaths, or an absence of breath(s). Since the movements of the MLRD 100, 101 are done in real-time, the airway of the user can be opened without disturbing the sleep of the user or wake related fitness or any other activity of the user. Algorithms designed to record, interpret, and analyze, execute commands, and facilitate servo feedback functions will contain tolerance range, critical values, and reportable values. Similar application may be appropriate for sports, athletics, performance, and military users. The controller station may be miniaturized using PIC / QMC microprocessors in aAttorney Docket 12572.012WO1hand-held device or wearable apparatus, such as a wristwatch, wrist band, helmet, waist belt, etc. or may be incorporated into an aircraft or space-ship’s internal computing system.
[0176] The controller station 200 has a microprocessor configured to process the data and instruct the MLRD 100, 101. However, the controller station 200 can communication with a server, such as a cloud server, for further processing if desired, or for additional memory storage and / or communication of the data to authorized healthcare providers and / or sleep analysis experts, etc. and / or communicate with a database of said person. This intercommunication of databases can create therapeutic interventions and diagnostic testing of a user while at home, in place of work, outer space or anywhere in the world. This system 300 enables an authorized healthcare provider with capability to monitor and record patient data in real time, learn the patient, and alter the patient’s treatment in real-time. The communications to and from the server can be through a wired or a wireless connection. The system 300 can also be configured to send data to a pharmacy, emergency medical services or HIPPA validated designated caregiver.
[0177] The server can also send commands, configuration data, software updates, and the like to the controller station 200. The configuration data may include, but is not limited to, configuration parameters for the system 300, configuration parameters for a particular user, and / or notifications, feedback, instructions, or alerts for the user.
[0178] The system 300, in addition to the MLRD 100, 101 can wirelessly communicate with additional sensors connected to the user to provide a broader data set for a more complete picture of the user’s physiology. For example, electrocardiogram (EKG), electromyography (EMG), electrooculography (EOG), electroencephalography (EEG) sensors, echocardiography, blood pressure monitoring systems, and sensors sensing environmental conditions, such as temperature, ambient light, and humidity. The system may include a camera for video recording through the controller station 200 to evidence any nocturnal seizures, sleep-walking, other movement or violent disorders during sleep.
[0179] In operation, data from the sensors on the MLRD 100, 101, such as oxygen measurements and pulse data, is sent to the controller station 200 to be processed by the microprocessor to determine how much movement of the protrusive flange by activation of the second driver is needed, how much movement of the first driver is needed to separate the jaws of the user, and if and when to stimulate the transverse lingual muscle of the tongue to move the tongue forward. After some breaths, the controller station 200 may determine to stimulate the tongue and activate the second driver to move the mandibular piece, and hence the jaw of the user, forward (anterior) or backward (posterior) direction. In other instances, the controller station 200 may determine to stimulate the tongue and activate both the first driver and theAttorney Docket 12572.012WO1second driver to separate the jaws and move the mandibular piece forward in order to adequately open the airway of the user.
[0180] The system 300 also creates three-dimensional images and videos of breathing, cardiac function, carotid blood flow data, eye-movements, jaw movements and brain EEG recordings for identification of medical conditions and interventions that may be useful to correct or treat those medical conditions. A unique advantage of this system over any other existing systems is that the jaw and tongue can move synchronously, independently, or sequentially during sleep or during wake-related activities, in real-time and in anticipation of impending airway closure or changes in physiology, and in a provision of a measured response to those changes such as relief from, restriction of airflow as determined by the controller station 200 even before the airway has completely closed; thus, restoring unrestricted airflow even before the patient has completely stopped breathing (as in sleep apnea). This system can see airway obstruction before it happens and will keep the airway constantly open in any body position or depth of sleep. This is a distinct advantage over CPAP / BIPAP or any other mechanical or electrical system that is commercially available in the market. In addition, there are distinct advantages just by the breadth of functionality that has been described above. Additional features of the controller station 200 and system 300 are described in detail in U.S. Patent No. 11,484,434 and pending application No.17 / 098,355.
[0181] MRDs can increase the narrowest cross-sectional area (SMCA) that is the limiting factor. With reference to FIG. 30, incremental reduction in airflow resistance and increase in airflow and oxygenation with lesser work of breathing will delay dehydration, sweating, body heat rise, fatigue and keep the heart rate at a lower level (within the fat burning range) while offering higher amount of calorie consumption for a longer period of time, thus increasing the possibility of successful weight loss. It is also expected that users will experience an improvement in personal self-image, emotional markers and mental health, and possibly an increase in endorphins and decrease in adrenaline production during exercise and better control of diabetes and blood sugar problems. Additionally, for physical activity uses, the mandibular repositioning devices, each of the mandibular piece and the maxillary piece in particular, can include a shock absorbing feature, such as sealed air pockets to cushion the teeth from impact and prevent wear and tear on the TMJ, or one or more polymer layers inside an outer acrylic hard shell, or a soft outer polymer on the frictional surface of the mandibular and maxillary pieces. In one embodiment, one or both of the mandibular piece and the maxillary piece have an outer hard acrylic shell and inner soft polymer with a 0.02 to 0.5 mm continuous layer of air with supports at the cusp of the teeth and horizontal band of supports across the mid-dental plane of the maxillary and mandibular teeth.Attorney Docket 12572.012WO1
[0182] Referring now to FIGS. 31 to 32, Algorithm I and the results for one individual as example are shown. Algorithm I predicts the total anterior vertical mandibular lingual repositioning adjustments for effective use of the mandibular repositioning devices herein with a user during physical activities, such as weight loss, athletics, military, and aerospace activities. The baseline heart rate is the heart rate at rest for a selected user. The target hear rate is the heart rate that is selected by the user or a professional assisting the user with the physical activity such as a coach, fitness expert, doctor, physical therapist, etc. For example, a heart rate that is less than 70% of the peak heart rate may be desired for fat burning activities and can be used in a weight loss program. The peak heart rate is a variable that is dependent upon the age of the selected user and is not gender specific.
[0183] Airflow resistance is determined by setting a fixed length of airway to 10 cm and the air viscosity to 1.81 (typical for normal elevations). An increase in airflow resistance causes an increase in heart rate, respiratory rate, work of breathing, and core body temperature, and affects calorie or energy consumption, water loss through sweat, and evaporation through breathing.
[0184] Referring now to FIGS. 33 to 35, Algorithm II and results for one individual as an example are shown. The use of Algorithm II for physical activity monitoring, such as during a sporting activity, is meant to be used to improve the individual’s performance, such as work efficiency, lower heart rate, etc. while mitigating risk of deterioration from other indices, such as dehydration, core body temperature, etc.
[0185] The actual exercise heart rate is measured during a preselected activity. In one embodiment, the preselected activity is running on a treadmill at 4 miles per hour while at a 5% incline. The change in heart rate is important for determining the progress of the individual at a fitness program or physical activity. Monitoring the incremental increase / decrease in the heart rate with adjustment of TAVMLR or intensity of exercise provides a new method of monitoring an individual. The physical activity can be adjusted for the individual at any given time including adjustment of the TAVMLR for the mandibular repositioning devices disclosed herein to create an optimal size of SMCA for the level of exercise desired at that time.
[0186] The respiratory rate is a determinant of the work of breathing, which is dependent on oxygen consumption, demand, and cardio-pulmonary coupling. The faster an individual breathes, the greater the work being performed and the earlier the individual will be fatigued. It also determines the generation of body heat and amount of water evaporation (dehydration). The minute ventilation (MV) has a proportion relationship to the respiratory rate. However, with increasing respiratory rate there is also an increase in dead space ventilation and the proportion of alveolar ventilation for each breath begins to decrease. This creates inefficiency of breathing seen in Table 4 above. Increasing inefficiency of breathing (the greater the respiratory rate)Attorney Docket 12572.012WO1generates greater lactic acidosis which clouds consciousness and decision making, produces easy muscle cramps with deterioration in coordination, and creates higher heart rates. It is very important to keep the minute ventilation (respiratory rate) in a manageable (in a range so as to maintain greatest efficiency of breathing or lowest airflow resistance) range to optimize the individual’s work, i.e., minimize effort and maximize performance.
[0187] The air pressure or airway pressure is the pressure generated by forceful inhalation and exhalation. It is reflective of the work of breathing but also is a determinant of airway resistance. It may cause the airway to be sucked inward (Bernoulli’s effect) during inspiration which decreases the SMCA further and deteriorates performance. An increase in pressure may precipitate exercise induced asthma. The work of breathing, typically, needs to be maintained at <10% of the basal metabolic rate (BMR) for an endurance athlete. Greater values are reflective of greater calorie consumption and may be desirable for weight loss programs. These algorithms help set a “work of breathing” variable to suit the intended or desired result.
[0188] Increasing core body temperature can be a source of dehydration and rapid fatigue. It may also generate conditions like heat stroke and all its associated complications like rhabdomyolysis, in endurance athletes. The closer this value is to baseline, the safer for the individual. This value is dependent on heart rate and airway resistance, with the airway resistance being dependent on the size of SMCA. Each heart rate increase of 10 beats per minute increases the core body temperature by EC.
[0189] Dehydration is expressed in the Algorithms as milliliters per hour. Many individuals fail to complete an activity because of poor management of dehydration. Dehydration is also a factor in injuries suffered during physical activity. Muscle weakness and cramping and decreasing blood pressure due to decreasing intravascular volume are important complications of dehydration. Water loss is inevitable. Understanding the anticipated volume of water loss and replacing it judiciously is now possible because the algorithms estimate the volume of water loss.
[0190] An individual that experiences a decrease in the systolic blood pressure (SBP) with exercise is referred to as a “Dipper.” Such a decrease in the SBP is a predictor of cardiovascular risk of myocardial infarction and cardiac arrhythmia. A severe increase in SBP is associated with exercise related cardiac complications like stroke and cardiac arrhythmia. Algorithm II enables the SBP to be monitored, thereby enabling the identification of either fluctuation in the SBP for timely intervention and / or prevention of such complications during physical activity. The double product (DP) output of Algorithm II is the SBP multiplied by the pulse rate. This numerical value is used in stress tests as an index of myocardial oxygen consumption. A safe range for DP is 14,000 to 18,000. DP can be monitored by Algorithm II during physical activity to prevent severe increases and decreases in cardiac oxygen consumption. For Dippers, the AlgorithmsAttorney Docket 12572.012WO1provide a TAVMLR value that when implemented in a mandibular repositioning device that is worn during physical activity can result in a healthy increase in SBP while reducing the heart rate using better provision of oxygen through an increased SMCA, thus keeping the DP within a safe range. Target Peak SBP = 1.2 * Resting SBP and the same goes for target DBP. In a Dipper, Target Peak SBP = 0.8 * Resting SBP. The multiplier 1.2 represents a 20% increase in SBP that occurs in normal individuals while the multiplier 0.8 represents the 20% drop in SBP from resting value.
[0191] Methods that include the algorithms are numerous. The method can determine the SMCA without requiring a CT Cone Scan of an individual’s airway, can determine the TAVMLR to manufacture a customized mandibular repositioning device of the kinds disclosed herein to improve an individual’s performance during physical activity, can determine and / or prevent a risk of a cardiac event during exercise, can build fitness programs to fulfill or satisfy a large range of variables and individual needs, can set incremental targets for any of the variables in either algorithm to increase physical performance, such as speed, endurance, ability to jump higher or longer, swim faster, can set incremental targets for any of the variables to reduce the TAVMLR in order to purposefully increase airway resistance to build greater endurance or decrease / increase airflow resistance to mimic conditions of extremely high or low G forces in space or in a military or civilian aircraft during distress, can predict target outcomes and set nutritional supplementation and hydration levels to maximize the success of such targets, can protect athletes and individuals from medical conditions like asthma, unsafe high or low levels of SBP or DBP, can be used in medical practice to adjust the TAVMLR to ease breathing or optimize cardiac performance in conditions like, but not limited to, cystic fibrosis, bronchiectasis, COPD and CHF, Angina, or to treat obesity or diabetes.
[0192] The methods include determining baseline parameters for a selected individual, the baseline parameters comprising age, baseline heart rate, respiratory rate, core body temperature, and minute ventilation while at rest, determining the air pressure for an exercise location of the individual, selecting a target heart rate for a preselected physical activity, and calculating the total anterior and vertical mandibular lingual repositioning (TAVMLR) for a mandibular repositioning device using one or more of Algorithms I and II. In one embodiment, the TAVMLR is calculated according to the equation:TAVMLR = 0.1839*(3.142*((8*Va*Lairway) / ((target heart rate - baseline heart rate) / (the air pressure * 100))1 4)2)wherein Vais the velocity of air = 1.81 and Lairway is the length of the airway = 10 cm.The TAVMLR value determines the amount of anterior repositioning and verticalAttorney Docket 12572.012WO1repositioning to include in the mandibular repositioning device of the selected user for an at rest position of the mandible.
[0193] For Algorithm II, the method includes measuring the individual’s actual exercise heart rate at a preselected activity and intensity. In one embodiment, the preselected activity and intensity is a run on a treadmill at 4 miles per hour at a 5% incline. In another embodiment, it is a brisk walk on the treadmill instead of a run. In another embodiment, it may be a brisk walk at 5 miles per hour at an 8% incline. The duration of the preselected activity may vary as part of the intensity, such as being for a half hour or 45 minutes, whatever the overseer of the physical activity deems appropriate for the individual to establish an exercise heart rate that fits the ultimate goal of the method.
[0194] The methods can include reviewing the output parameters of Algorithm II for any outputs that are outside of a desired range for the individual or for making intensity adjustments to the physical activity for the individual to prevent injury, medical emergencies, etc., and gradual changes in intensity (increases in particular) can be projected and implemented. For example, the double product is outside of the range of 14,000 to 18,000, the blood pressure is too high or too low for the individual, the heart rate is too high for fat burning exercise, etc.
[0195] In one embodiment, the individual has their blood pressure monitored while exercising for continual live updating of the Algorithms, especially Algorithm II. The live updating can be accomplished with a mobile device, computer, or other screen capable of displaying the data generated by the algorithms. If the individual is one whose systolic blood pressure (SBP) drops with exercise, e.g., SBP changes from 160 mm Hg to 128 mm Hg, the overseer of the exercise / physical activity can monitor this in real time and can terminate the exercise or reduce the intensity as needed. Software can connect the biometric parameters with the exercise equipment and even control the exercise parameters on the associated equipment (like treadmill or a stationary bicycle) such as slowing or speeding up the treadmill in response to the algorithm. The overseer of the physical activity may even create exercise scenarios to push the physiologic parameter outside of the normal range to increase the endurance or tolerance during physical activity of the individual for example so as to create conditions of severe stress in order to condition the individual to be properly conditioned for the physical activities demands. The individual as mentioned before can be an athlete, military personnel, astronaut, pilot, etc.
[0196] Moreover, the overseer can adjust the variables INPUT or OUTPUT in the Algorithms as needed to tailor suitable exercise conditions for individuals with pre-existing conditions. Some example conditions include, but are not limited to, asthma, COPD, cardiac arrhythmia, and excessive sweating syndrome. For example, if the individual has Asthma, the Desired Air Pressure can be selected to stay under 1.32 because expiratory airway pressure rises withAttorney Docket 12572.012WO1intensity of exercise can precipitate an attack of exercise induced asthma. In this example, we still want the Target % Peak HR to stay close to 55-60%. Using the Goal Seek tool in the Excel program, we set the Target Airway Pressure to 1.32 and the algorithm then creates the scenario for safe athletic training at 1.32.
[0197] It should be noted that the embodiments are not limited in their application or use to the details of construction and arrangement of parts and steps illustrated in the drawings and description. Features of the illustrative embodiments, constructions, and variants may be implemented or incorporated in other embodiments, constructions, variants, and modifications, and may be practiced or carried out in various ways. Furthermore, unless otherwise indicated, the terms and expressions employed herein have been chosen for the purpose of describing the illustrative embodiments of the present invention for the convenience of the reader and are not for the purpose of limiting the invention. Having described the invention in detail and by reference to preferred embodiments thereof, it will be apparent that modifications and variations are possible without departing from the scope of the invention which is defined in the appended claims.
Claims
Attorney Docket 12572.012WO1What is claimed is:
1. A method for restoring oxygen delivery in a user experiencing exercise-induced arterial hypoxemia, the method comprising:determining at least one EIAH-related biologic data of the user;inputting the at least one EIAH-related biologic data and preselected biological data of the user into a predictive algorithm stored in nontransitory memory of a microprocessor; generating, via the predictive algorithm, a flange geometry for a mandibular repositioning device configured to increase the user’s partial pressure of oxygen (PaCh) to at least a reststate value during exercise; andfabricating the mandibular repositioning device according to the flange geometry generated by the predictive algorithm.
2. The method of claim 1, wherein fabricating the mandibular repositioning device comprises 3-D printing and / or additive manufacturing thereof.
3. The method of claim 1, wherein the mandibular repositioning device comprisesa maxillary piece having a driver flange protruding laterally outward on either or both of the right side and left side thereof, each driver flange having an anterior side with a convex curvature; anda mandibular piece having a protrusive flange extending cranially therefrom positioned to have a posterior side engaged with the anterior side of the driver flange, the posterior side of each protrusive flange has a concave-to-convex curvature from a base of the protrusive flange toward a most cranial point of the protrusive flange and a convex portion of the concave-to convex curvature engages the convex curvature of the driver flange in a rest position.
4. The method of claim 3, wherein the mandibular piece has a plateau of a preselected height between a base of the protrusive flange and the mandibular piece.
5. The method of claim 1, wherein the mandibular repositioning device comprises:a mandibular piece comprising a platform along a superior occlusal surface that defines a first ramped surface with a rise oriented anteriorly and a first flange extending cranially upward from an anterior end of the platform, wherein the posterior side of the first flange is oriented at a posterior lean in a range of 3 to 20 degrees relative to the superior occlusal surface and contoured as a (i) concave curvature or (ii) a concave-to-convex surface in the caudal to cranial direction;Attorney Docket 12572.012WO1a maxillary piece comprising a second flange that extends caudally downward from an inferior occlusal surface thereof, wherein, in a rest position, the second flange has a caudal side shaped to seatingly mate to the platform of the mandibular piece and an anterior side with an opposite surface contour shaped to seatingly mate to the posterior side of the first flange, thereby defining a wedge-shaped column having its rise defined by the height of the first flange separating the mandibular piece from the maxillary piece and defining a static open mouth position,wherein the static open mouth position is configured to maintain a user’s oxygen concentration in the bloodstream at a pre-selected concentration, and downward movement of the mandibular piece moves the posterior side of the first flange along and in contact with the anterior surface of the second flange for gradual incremental forward mandibular movement, which increases the cross-sectional area of the user’s airway.
6. The method of claim 1, further comprising validating the user’s secondary biometrics while wearing the mandibular repositioning device with the flange geometry.
7. The method of claim 6, wherein validating includes measuring the biometrics during peak performance conditions.
8. The method of claim 6, wherein validating includes inputting the secondary biometrics into the predictive algorithm and assessing calculated biometrics.
9. The method of claim 8, further comprising fabricating a secondary version of the mandibular repositioning device.
10. The method of claim 6, further comprising repeating the method as the user’s physical performance improves or the user’s biometric values change.
11. The method of claim 1, wherein the predictive algorithm comprises the calculated values in the table below.EFFECTIVE TAVMLR / RAP FORMULA: DESIRED SaOz% (EXERCISE & SLEEP RECOVERY)D E FLowest SaOz% Minimum Mouth Open Desired SaOz%(ISaOz) (MnMO°)14 Enter User's Data Enter User's Data Enter User's DataAttorney Docket 12572.012WO1Effective TAVMLR Effective RAP Anterior position at MxMO (mm3) (mm) (mm)17 =(E14-D14) / 0.8141 =$D$17-(F14*0.346) =E17+15PREDICTED O2 SAT FROM PRESELCTED TAVMLR AND LSAT FOR EXERCISE OR SLEEP RECOVERYLowest SaOz% Pre-selected TAVMLR Restored SaOz% (lSaO2EXERCISE) (mm3) (rSaOi best VOz max) 24 =D14 Enter User's Data =$D$24+(0.8141*$E24) 25 =E24-1 =$D$24+(0.8141*$E25) 26 =E24-2 =$D$24+(0.8141*$E26) 27 =E24+1 =$D$24+(0.8141*$E27) 28 =E24+2 =$D$24+(0.8141*$E28)29 =E23+3 =$D$24+(0.8141*$E29)12. The method of claim 11, wherein the predictive algorithm comprises the calculated values in the tables belowD E F OBSERVED BIOM ETRIC INPUTS THAT DB LIVE pExercise outputs BIOMETRICS MALE FEMALE33 AGE (in years) Enter User's Data Enter User's Data34 Weight in lbs Enter User's Data Enter User's Data35 Hemoglobin (gm / dl) Enter User's Data Enter User's Data36 Resting Heart Rate Enter User's Data Enter User's Data (Actual)37 pHeart rate at ISaOi Enter User's Data Enter User's Data (Actual)38 pHR at pExercise at Enter User's Data Enter User's DatarVOimaxandVOimax Consumption mL / Kg / min (Age dependent v / s Actual)I J PEAK OUTPUTS (NATIVE) MALE FEMALE 14 AGE (in years) =E33 =F3315 Peak Heart Rate (age dependent) =220-114 =220-J 14 16 Resting Heart Rate (Actual) =E36 =F3617 Max Heart Rate (Actual exercise) =E37 =F37=15.3*(I15 / I16)- =15.3*(J15 / J16)*0.75- 18 V02max Consumption (Peak HR) (0.01*(I14-25)) (0.01*(J14-25)) =15.3*(I17 / I16)- =15.3*(J17 / J16)- 19 V02max Consumption (Max HR) (0.01*(I14-25)) (0.01*(J14-25)) 20 Lactate Threshold (LR) %V02max =0.83*119 =0.83*J1921 Critical Power Relative (CPR) =0.75*119 =0.75*J19Attorney Docket 12572.012WO122 Critical Power Absolute (CPA) =0.85*119 =0.85*J19DChmax ml / Kg / min; VChmax ml / Kg / min at peak exercise (pExercise) COMPARISON NATIVE / AIODEVICES MALE FEMALE26 lSaO2 during exercise native =D14 =D1427 pHeart rate at lSaO2 =117 =J 1728 IVO2 max consumption at!SaO2 / pHR (peak exercise heart rate) =119 =J1929 Hemoglobin gm / dl =E35 =F3530 Weight in lbs =E34 =F3431 Cardiac Stroke Volume (avg) Enter User's Data Enter User's Data =(I31-((I17- I16)*0.01))*I17* =(J31-((J17- ((1.34*I29*(0.01*$D$14 J16)*0.01))*J17* ))) / ((1.34*J29*(0.01*$D$14))) / 32 D02max (Delivered O2) ml / kg / min ((I30 / 2.2)*60) ((J30 / 2.2)*60) 33 rSaO2 during exercise (%) AIO =F24 =F2434 A(DO2max-VO2max) =132-128 =J32-J3835 pHR at pExercise at rV02max =E38 =F38=15.3*(I35 / I16)- =15.3*(I35 / J16)*0.75- 36 rV02max consumption (pHR) (0.01*(I14-25)) (0.01*(J14-25)) =(I31-((I35- =(J31-((J35- I16)*0.01))*I35* J16)*0.01))*J35* ((1.34*I29*(0.01*133))) / ((1.34*J29*(0.01*J33))) / 37 rD02max (Delivered O2) ml / kg / min ((I30 / 2.2)*60) ((J30 / 2.2)*60)56.65 38 A(rDO2max-rVO2max) 137-136 J37-J3639 | Restored Lactate Threshold (LR)%V02max =0.83*136 =0.83*J3640 Restored Critical Power Relative(CPR) =0.75*136 =0.75*J3641 Restored Critical Power Absolute(CPA) =0.85*136 =0.85*J3613. The method of claim 4, wherein the plateau has a height in a range of 8 mm to 24 mm and produces a vertical dimension of occlusion (VDO) in a range of 12 mm to 24 mm between the mandibular piece and the maxillary piece.
14. The method of the preceding claim, wherein the posterior lean angle of the protrusive flange is in a range of 4 degrees to 20 degrees from vertical.
15. The method of claim 1, wherein the mandibular repositioning device further comprises a lingual flange extending inferiorly and lingually from a lingual surface of the mandibular piece on each of a left side and a right side thereof, each lingual flange having a subglossal shelf depthAttorney Docket 12572.012WO1measured from the lingual gingival margin in a range of 12 mm to 24 mm and a lingual angle measured from the lingual gingival plane in a range of 15 degrees to 60 degrees.
16. The method of claim 4, wherein the protrusive flange has a vertical flange height measured from the cranial surface of the mandibular plane in a range of 24 mm to 36 mm.
17. The method of claim 1, further comprising classifying EIAH severity of the user as mild (SaO2 nadir 93-95%), moderate (SaO2 nadir 88-93%), or severe (SaO2 nadir below 88%) from the physiologic data, and generating geometry-defining parameters scaled to the classified severity.
18. The method of claim 1, wherein the predictive algorithm determines a minimum mouthopening height.
19. The method of claim 8, further comprising training the predictive algorithm using historical physiologic data, the historical data comprising exercise-phase physiologic measurements obtained during graded exercise testing at intensities at or above lactate threshold.
20. A computer-implemented method for generating a geometry for an oral appliance configured to improve oxygen delivery in a user, the method comprising:receiving, by a processor, physiologic, biometric, or anatomic data of the user; processing, by a predictive algorithm stored in non-transitory memory, the physiologic, biometric, or anatomic data; andoutputting, by the predictive algorithm, one or more geometry -defining parameters for the oral appliance, the geometry-defining parameters comprising at least one of an anteroposterior advancement distance, a cranial-caudal repositioning distance, a volumetric repositioning value, or a mouth-opening value,wherein the geometry-defining parameters are generated to increase oxygen delivery or maintain oxygen saturation of the user during physical exertion.
21. The method of claim 1 or 20, wherein the physiologic data comprises oxygen saturation, partial pressure of oxygen, or lowest oxygen saturation during exercise, the biometric data comprises heart rate, resting heart rate, peak heart rate, respiratory rate, body temperature, hemoglobin concentration, age, or weight, and the anatomic data comprises airway cross-Attorney Docket 12572.012WO1sectional area, mandibular position, tongue-base morphology, or cone-beam computed tomography measurements.
22. The method of claims 1 or 20, wherein the predictive algorithm comprises one or more of a machine-learning model with a neural network, a regression model, a rules-based model, and a hybrid physiologic -mechanical model.
23. The method of claim 20, wherein the predictive algorithm is trained using historical physiologic data, airway imaging data, or performance data.
24. The method of claim 1 or 20, wherein the geometry-defining parameters comprise an Effective TAVMLR value, an Effective RAP value, an anterior position at maximum mouth opening, and a predicted static open-mouth position.
25. The method of claims 1 or 20, further comprising generating one or more of a predicted restored oxygen saturation value for the user during physical exertion, a predicted restored VCEmax value for the user, a predicted restored DCEmax value for the user, a predicted lactate threshold value for the user, and a predicted critical power value for the user.
26. The method of claims 1 or 20, further comprising receiving secondary physiologic or biometric data collected while the user wears the oral appliance during physical exertion.
27. The method of claim 26, further comprising reprocessing, by the predictive algorithm, the secondary physiologic or biometric data.
28. The method of claim 27, further comprising outputting, by the predictive algorithm, updated geometry -defining parameters for a second oral appliance.
29. The method of claims 1 or 20, wherein the predictive algorithm is executed on a cloudbased server, a mobile device, or an embedded processor.
30. The method of claim 20, wherein the predictive algorithm generates a geometry that increases oxygen delivery beyond the user’s natural baseline.
